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ABSTRACT
Insulin receptor assays using canine liver membranes and 
erythrocytes were validated for use In evaluating Insulin receptor 
binding parameters within a healthy population of dogs. Association, 
dissociation, saturabllity and specificity were demonstrated for 
Insulin receptors of canine liver membranes and erythrocytes. Assay 
precision was evaluated by measuring Interassay coefficient of 
variation (liver membrane " 25.OX; erythrocytes ” 9.3%).
Because the number of hlgh-affinity receptor sites and high- 
affinlty K^ were determined using physiological concentrations of 
insulin, they were considered to be more physiologically important 
than the total number of receptor sites, low-affinlty Kp and Ke, which 
were derived using supra-physlologlcal concentrations of insulin. The 
X maximum binding correlated with the number of high-affinity receptor 
sites and Ke, but negatively correlated with high-affinity Kp.
In addition to correlating binding parameters within and between 
tissues, the effects of sex, anesthesia and prednisone treatment were 
evaluated. Erthrocyte Insulin receptor binding did not correlate well 
with liver insulin receptor binding (3 samples of 12 dogs; Pearson's 
correlation coefficient). This lack of correlation was possibly due 
to different mechanisms of receptor regulation or poor precision In 
the liver membrane assays.
No significant differences were observed in mean values for 
binding parameters observed when comparing male versus female dogs for 
either liver membranes or erythrocytes using an unpaired t test (p > 
0.05). However, there was a significantly greater variation in the %
XV
maximum binding and the number of high-affinity receptor binding sites 
for erythrocytes among females (Prob (a greater F) - 0.0405 X MB;
0.0035 Hi-Affinity Sites).
A significant decrease in the X maximum binding of erythrocyte 
insulin receptors was observed as a result of anesthesia (paired t 
test; p “ 0.028).
No significant changes in erythrocyte insulin binding were 
observed in 6 male dogs given daily prednisone, when evaluated at 52 
hours and 3 weeks after onset of treatment (paired t test; p > 0.05).
Canine erythrocyte insulin receptors are a potentially valuable 
tool In evaluating clinical syndromes where alterations in insulin 
receptor binding may occur.
xv i
INTRODUCTION
Insulin Is a peptide hormone, having a molecular weight of 6000, 
which is secreted by the beta cells of the pancreas. It elicits a 
number of biological responses and plays a central role in the 
regulation of carbohydrate, fat and protein metabolism fFlier, 1983], 
Although liver, muscle and fat tissues are the major physiological 
targets of insulin, many other cell types are regulated by Insulin 
r Czech, 1985].
Biological actions of insulin include the activation of transport 
systems for hexoses, amino acids and certain ions. Lipid and 
carbohydrate metabolism are affected by insulin*s activation of 
enzymes such as glycogen synthase and pyruvate dehydrogenase, as well 
as inhibition of hormone sensitive lipase TCzech, 1985]. Insulin also 
modulates DNA and mRNA synthesis, protein synthesis and cell growth 
[Belcher & Bar, 1981].
Evidence suggests that the biological actions of insulin are 
Initiated by the interaction of the hormone with specific cell-surface 
receptors that mediate one or more cellular signaling mechanisms 
TCzech. 1985]. These signaling mechanisms are Implemented by membrane 
synthesis of one or more chemical mediators or second messengers which 
have not been clearly identified [Belcher & Bar, 1981].
Insulin binding to its plasma membrane receptor Is altered in a 
number of clinical disease states, resulting in insulin resistance 
fBar, 1983], Insulin resistance is defined as a condition where 
greater than normal amounts of insulin are required to elicit a 
quantitatively normal response. Recognized clinical states of insulin
2resistance Include diabetes mellltus (Type I & II), obesity. Cushings 
syndrome (excess glucocorticoids!, acromegaly (excess growth hormone), 
pregnancy, ketoacidosis, Insulin antibodies, uremia, cirrhosis, 
sepsis, and burns. Mechanisms for this Insulin resistance Include 
decreases In the number of receptor sites, decreases In receptor 
affinity or both fBelcher & Bar, 1981’. Insulin resistance may also 
result from synthesis of defective Insulin molecules, abnormal Insulin 
degradation, insulin antibodies or post-receptor defects )Bar, 19831.
The term "physiological receptor" refers to the hormone-receptor 
binding that occurs i^i vivo and is linked to a biological response in 
vivo [Limbird, 1986). The intent of radioreceptor assays is to 
monitor the Interaction of this physiological receptor for a 
particular hormone. The basic methodology employed for direct studies 
of insulin-receptor interactions Is the same as other competitive 
protein binding assays. A radiolabeled hormone or ligand is Incubated 
with a suitable receptor preparation, then separated so that receptor 
bound radioactivity is determined. The specificity and saturabllity 
of these binding interactions are determined by performing incubation 
with various amounts of unlabeled hormone TKahn, 19761. These 
radioreceptor binding assays may be employed to evaluate physiological 
and pathophysiological changes in receptor binding.
The use of radioreceptor assays involving erythrocytes or liver 
membranes has not been thoroughly validated for use in the dog. Since 
there are recognized clinical syndromes of insulin resistance in dogs 
TElgenmann & Peterson, 1984), it would be worthwhile to have a means 
to evaluate the insulin receptor in these states of insulin 
resistance. Because of easy access to venous blood by venipuncture,
3the erythrocytes have an obvious advantage over liver membranes, 
obtained by liver biopsy, when evaluating insulin receptor status of 
an animal. If the erythrocyte insulin receptor represents the insulin 
receptor status of insulin target organs (liver, muscle, adipose), 
erythrocyte insulin receptor assays would be an ideal research tool 
for studying clinical syndromes of insulin resistance.
The objectives of this study are:
i) to demonstrate that the radioligand binding to canine liver 
membranes and erythrocytes, observed in the assays performed in this 
study, actually represents the interaction of the physiological 
receptor for insulin. To confirm this hypothesis, the following 
criteria will be demonstrated: a) association, b) dissociation, c> 
saturability and d) specificity.
ii) To establish the range of variation and correlate the a) number of 
receptor binding sites, b) receptor affinity and c) percentage of 
maximum binding of insulin receptors of erythrocytes and liver 
membranes from a sample population of healthy dogs.
iii) To determine the effects of administering glucocorticoids on the 
a) number of receptor sites, b> receptor affinity and c) percentage of 
maximum binding of insulin receptors of erythrocytes from male dogs.
LITERATURE REVIEW
I. RECEPTOR STRUCTURE AND FUNCTION
In the early 1900*3, investigators theorized the presence of 
"receptor substances" which reacted with given chemical agents to 
evoke a biological response fBelcher & Bar, 19811. In the 1920's,
A.J. Clarke proposed the simple hypothesis that the reaction between 
an active substance and its specific receptor is a reversible process 
governed by the law of mass action and that responses to the agent are 
directly proportional to the fraction of specific receptor occupied by 
the agent.
The roles of a ligand receptor are 1) to distinguish a particular 
signal from a mixture of other hormones and molecules and 2 ) to relay 
this signal in such a manner that the appropriate cellular response 
follows ^Baxter & Funder, 19791. Demonstration of a hormone binding 
site as a receptor requires it be purified and shown to elicit 
appropriate physiologic action when it binds the hormone in a defined 
system with proper controls. Identification of hormone binding sites 
as receptors has relied mainly on 11 correlation between hormone 
binding and biological effects, 2 ) genetic or other studies where 
changes in receptors are associated with altered hormone 
responsiveness, and 3) finding that receptor binding by anti-receptor 
antibodies or antagonists attenuates or alters the hormone responses.
Understanding the recently elucidated insulin receptor structure 
is important since receptor functions are determined by insulin 
receptor structure rCzech. 1985]. Native cell surface insulin
5receptors consist of 2 glycoprotein subunit types with apparent masses 
of about 125,000-135,000 daltons (alpha subunits) and 90,000 daltons 
(beta subunits). The alpha and beta subunits are derived from a 
single polypeptide precursor by one or more proteolytic cleavages.
The alpha subunit Is a glycoprotein containing an oligosaccharide and 
sialic acid; the beta subunit Is also a glycoprotein containing 
oligosaccharide. The alpha and beta subunits seem to have distinct 
functions in that the alpha subunit appears to bind the hormone 
whereas the beta subunit appears to possess Intrinsic tyrosine kinase 
activity. The predominant subunit configuration in the native insulin 
receptor is a disulfide-linked heterotetramerlc structure containing 2 
alpha and 2 beta subunits.
The chemical mediator(s) for insulin response have not been 
clearly defined. Other recognized second messengers such as cyclic 
AMP, cyclic GMP, calcium, magnesium and H2®2 were initially proposed 
but not substantiated fLarner, 1983; Gammeltoft, I9841. The 
observation that receptor-bound insulin was internalized suggested 
that intracellular receptors, insulin or proteolytic fragments may 
elicit the biochemical actions. This hypothesis has been dismissed 
because blocking of internalization and cellular degradation did not 
affect insulin activation of glucose transport and oxidation in fat 
cells oramino acid transport in hepatocytes fGammeltoft, 19841.
Studies using antireceptor antibodies have shown that the 
attachment of a monovalent Fab* fragment to an insulin receptor 
inhibited insulin binding and bioactivity of the receptor. If 
multiple Fab* fragments were crosslinked on receptor complexes, the 
bioactivity of the receptor was restored. This insulinomimetic effect
6suggests that receptor crossllnklng or aggregation may be Important 
for Insulin action [Cheng, 1985; Czech, 1985],
This evidence supports the theory that ligand binding by insulin 
receptors results in 1 or more conformational changes in receptor 
structure so that a variety of functions may proceed. [Czech, 1985]. 
Some Investigators feel that a small peptide mediator or a family of 
mediators are formed from cell membrane proteins or glycoproteins by a 
process of limited proteolysis which is modulated by binding of 
insulin to its receptor [Larner, 19851.
Proposed intracellular mechanisms for these mediators include 1) 
control of phosphorylation, 2 ) control of affinity for calcium or 
calmodulin, 3) control of fluidity of membranes or 4) direct 
allosteric effects [Jarett, 1983'. Abnormal release or metabolism of 
these mediators has been proposed as a mechanism for post-receptor 
defects in insulin function resulting in insulin resistance [Jarett,
1983].
Other investigators support the theory that the insulin receptor 
actually serves as an enzyme that catalyzes tyrosine 
autophosphorylation of the beta subunit TCzech, 1985], This enzyme 
(insulin receptor) is activated by insulin hormone to activate 
receptor tyrosine kinase activity. An interrelationship has been 
demonstrated between the proposed proteolytic formation of mediator(sl 
and receptor phosphorylation fChang, 1985],
While insulin-receptor complex internalization probably does not 
play an Important role in bioresponse as a second messenger, it does 
play a role in the cellular degradation of insulin as well as the 
regulation of receptor concentration [Bergeron, £t^  al^ . , 1985]. I_n
7vivo studies In man suggest that Insulln-receptor complex 
Internalization plays an Important role In the kinetic removal of 
Insulin from the circulation. Insulin removal by internalization Is a 
major function in the liver* receiving portal blood high in Insulin 
concentrations * but also occurs In extra-hepatic tissues f Eaton *
1984].
The process whereby there is a decrease in response to hormone at 
the cellular level has been called desensltlzation, tachyphylaxis or 
down regulation [Belcher & Bar, 1981]. Proposed mechanisms for this 
down regulation Include 1) reduced receptor affinity due to 
co-operative Interactions; 2 ) reduced numbers of receptors due to a) 
receptor release from membrane to the extracellular space, b) 
receptors inactivated by conformational changes, cl membrane receptors 
degraded at the cell surface, d) ligand binding to cell surface 
receptors Inducing Internalization; 3) inhibition of de novo synthesis 
of new receptors; 4) uncoupling of receptors from second 
messengers/mediators and 5) blockage of the effector pathway distal to 
the insulin-receptor interaction.
It is well recognized that insulin can inversely regulate the 
number of cell—surface insulin receptors [Marshall & Olefsky, 1981]. 
The fact that the rate of receptor loss correlates with the 
extent of insulin-receptor internalization, strongly suggests that 
this is an important mechanism for down regulation of receptor. 
[Marshall & Olefsky, 1981]. The insulin molecule is degraded while 
the receptor is sequestered in Intracellular vesicles. These vesicles 
can be degraded or recycled to the cell membrane Macobs &
Cuatrecagas, 1983],
8Physiological modulators of Insulin receptors Include Insulin, 
other hormones, exercise, meals, diet, age, cAMP, pH, ketones and 
antireceptor antibodies [Bar, 19831. Besides receptor 
Internalization, there are other mechanisms for regulation of insulin 
receptors. As previously described, the microaggregation of receptors 
resulting in conformational changes may be important for insulin or 
antireceptor antibodies to attach to receptors for generating 
intracellular signals. Modification of the plasma membrane lipid 
environment can also alter Insulin receptor function.
II. ASSAY BINDING TECHNIQUES
A. THEORY
The direct study of insulin-receptor interactions utilizes 
techniques similar to other competitive binding assays fFreychet, 
1976]. Assays of insulin receptor binding have 3 fundamental 
requirements: M  a radioactively labeled hormone (radioligand), 2 ) a
tissue receptor preparation and 3) a separation technique for 
separating bound and free hormone fFreychet, 1976; Gammeltoft, 1984; 
Limbird, 1986],
The reaction studied involves the binding of hormone, fH1, to its 
receptor, fR]. This reaction behaves according to the law of mass 
action i.e., the binding of a single ligand to a single population of 
homogenous binding sites by a fully reversible reaction fLimbird, 
1986], This reaction is represented by the following equation:
9fH] + [R] [HR]
where [H] * hormone (or *H - radiolabeled hormone)
[R] • receptor
THR] * hormone receptor complex 
k^ - association rate constant 
“ dissociation rate constant
An understanding of binding assay techniques requires an 
knowledge of radiolabeling of hormones and the conditions of the 
preparation of tissues containing receptors. Variation in assay 
conditions for incubation and separation can influence measured 
binding as well. There are specified criteria which must be met to 
confidently establish that a radioligand binding assay really monitors 
interaction at the physiological receptor for a particular hormone 
[Limbird, 19861. The term physiological receptor refers to that 
hormone-receptor binding that occurs in vivo and is linked to a 
biological response observed _in vivo.
Criteria to support the theory that binding sites identified 
represent a genuine, "physiological receptor" include:
1) Saturabllity - The binding should be saturable since a finite 
number of receptors is expected in a biological preparation.
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2) Specificity - The specificity of the hormone competing with the 
radiolabeled hormone for binding to the receptor should parallel the 
specificity of that hormone in eliciting its physiological effects.
3) Kinetics - The kinetics of binding should be consistent with the 
time-course of the biological effect elicited by the hormone.
By definition, binding sites, which have been measured In binding 
assays meeting the previous defined criteria, are considered to be 
"physiological receptors" [Limbird, 1986].
B. RADIOLIGAND
A number of radioisotopes have been used in radloligand—receptor
I n  c I'll 'I ^  | i
binding techniques: H, I, I, P, and C fLimbird, 19861.
Radiolabeled insulin used in binding studies must retain the
biological activity of the native unlabeled insulin and the specific
activity (amount of radioactivity per given mass) of the radiolabeled
insulin must be high enough to permit the use of low concentrations
125
(near the physiological values). Because of these requirements, I
125
is most often used to radiolabel insulin. In addition, I can be
obtained virtually carrier-free (i.e., close to 1 0 0% isotope
abundance), it is counted with high efficiency In most gamma counters
and it has a suitable half-life (60.2 days) for efficient use
r Freychet, 1976].
Xodlnatlon of insulin is commonly performed by one of two methods
[Freychet, 19761. The chloramine-T method Involves the iodination of
125
microgram concentrations of insulin with Na I with only about 10% 
of the insulin being iodinated. Chloramine-T is added stepwise until
11
the desired degree of iodlnatlon Is achieved (usually 60-902 of the 
Iodine is incorporated into insulin). Iodlnatlon may also be 
performed enzymatically with the use of lactoperoxldase to catalyze 
the oxidation of iodine In the presence of fFreychet, 1976;
Frank, et al. 1983]. Iodlnatlon occurs on one or more of 4 tyrosine 
residues in the insulin molecule (A14, A19, BI6 , B26) [Gammeltoft, 
19841 .
Until recently, receptor—binding studies were performed with 
125
heterogenous I labeled insulin preparations fGammeltoft, 1984]. 
These lodlnated insulin preparations were composed of monoiodonated 
and dllodinated isomers, aggregated insulin polymers and native 
Insulin. Some of these preparations showed decreased biological 
activity due to oxidation damage and multiple iodine substitutions. 
These preparations altered binding assay studies by increasing 
non-specific binding and/or altering receptor concentrations or 
affinity depending on the position of iodines.
Several laboratories have succeeded in purifying monolodolnsulln 
by ion-exchange chromatography ^Gammeltoft, 19841 or high performance 
liquid chromatography [Frank, 1983], Homogenous preparations of 
raonoiodoinsulln differ in bioactivity according to which tyrosine 
residue on the insulin molecule is labeled. Insulin iodinated at TYR 
-A14 is fully active while insulin iodinated at TYR-A19 has attenuated 
activity, suggesting that TYR-A19 is included in the receptor-binding 
region of insulin. Preparations of monoiodoinsulin labeled at TYR-B16 
or TYR-B26 have Increased rates of association and the use of these 
preparations tend to erroneously over-estimate receptor affinity. The 
relative binding affinities of the four homogenous monoiodoinsulin
12
preparations are as follows: 0 (A19), 1 (A14), > 1 (B16 & B26)
[Gammeltoft* 1984]. In addition, the affinities of monoiodoinsulin
vary with the tissue and species being evaluated [Frank, e_t al^ 1983;
Podlecki, e^al, 1983].
Monoiodoinsulin labeled at TYR-A14 is felt by many investigators
to be an ideal radioligand to use in radioreceptor binding assays
because of its previously described bioactivity and binding affinity.
In addition, this preparation has shown bioactive and immunoreactive
stability for at least 6 months fLinde, et^  1981; Gammeltoft,
1984]. However, in one report of binding studies, decreases in the
apparent number of binding sites occurred by approximately 0.13% per
day of aging. The concentration of bioactive insulin in the
preparation decreases as a function of time because of the
125
disintegration of I causing an inactivation of the parent insulin 
molecule. There was no significant effect on the affinity of insulin 
to its receptor. [Mattinen, et^  al, 1984],
C. RECEPTOR PREPARATIONS
Receptor preparations usually fal1 into one of 3 classes:
1> isolated intact cells, 2) particulate f ractions of cells and 3^  
solubilized fractions of cells rFreychet, 1976; Kahn, 1976].
The study of isolated intact cells offers an advantage over 
tissue fraction preparations. The cells are metabolically active, 
therefore both binding of insulin, as well as biological effects of 
the hormone, can be measured. Also, the measurement of binding can be 
expressed per cell which is of interest when comparing binding
1 3
capacities between various physiological and pathophysiological 
states. Use of intact cells circulating In the bloodstream 
(monocytes, lymphocytes, and erythrocytes^ allows for easy 
accessability [Freychet, 1976],
An advantage of particulate fractions of cells (cell membranes)
Is that they can be stored for several weeks or months and samples 
from the same preparation can be repeatedly used. Two types of cell 
membranes have been employed. One type consists of relatively crude 
preparations which represent microsomal fractions. These preparations 
are prepared by differential centrifugation of the homogenate (usually 
in 0.25 M sucrose). The second type of cell membrane preparations, 
which are highly purified membrane preparations, require more steps in 
differential centrifugation. Even the most highly purified 
preparations are contaminated with 5-10% mitochondrial and microsomal 
proteins while less purified membranes may contain up to 90% of these 
contaminants [Freychet, 19761. The advantage of the more purified 
membranes include higher specific activity, lower non-specific binding 
and minimal insulin degradation; whereas, less purified preparations 
contain internal organelles which may possess specific or non-specific 
hormone binding sites fKahn, 19761. The purified membrane 
preparations yield 10—50% of the binding of less purified preparations 
and may not reflect total cell binding.
Solubilized fractions of cells and cell membranes are 
preparations where the receptor has been removed from its biological 
membrane so that the receptor can be studied for its own 
physlochemlcal properties rather than those of the membrane [Limbird, 
19861. There are obvious advantages to studying receptors in this
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state. Solubilization Is usually performed by biological detergents 
(bile salts, physiological emulsions) and may Introduce alterations In 
binding due to the effects of solubilization on membrane phospholipids 
f Kahn, 19761.
D. INCUBATION
The concentration of receptor-containing tissue and the duration 
of incubation necessary to obtain detectable binding are influenced by 
some of the consequences of the mass action law:
Association Rate ■ kj THl rR]
Dissociation Rate - k^HR]
At equilibrium Association Rate - Dissociation Rate
k L (H] [R] - k2 rHR]
The ratio of bound H ( as ]HR] ) to the reactants is:
fHR] - kx
--------------    K , molar ^A
[H1 f R] k2
where - Equilibrium Association Constant
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and f H ] f R ] ■ k2
fHR]
“ Kp, molar
where * Equilibrium Dissociation Constant
Kjj is most commonly used to represent the affinity of the
receptor because the units are molar rather than reciprocal molar.
represents the concentration of hormone that half-maximally occupies
the receptor at equilibrium. An increase in correlates with a
decrease in affinity.
Optimal incubation conditions are determined empirically for each
&
system and are chosen to optimize the formation of \ HR] while
*■
minimizing the degradation of f H] and fR] [Limbird, 1986],
E. SEPARATION OF BOUND FROM FREE RADIOLIGANDS
To determine the quantity of bound radioligand one must have a
k
method of terminating the incubation which a1lows separation of f H 1 
(free radioligand) from [ HR] (bound radioligand). Several methods 
are available including equilibrium dialysis, centrifugation and 
vacuum filtration. Equilibrium dialysis Is theoretically the most
it k
accurate way of determining f H] and [ HR] because equilibrium is not 
disrupted; however, there are some technical disadvantages. These 
Include cumbersome apparatus, long incubation, nonspecific absorption
1 6'
*
of f Hi to chamber walls and low specific radioactivity above 
background.
*
With centrifugation, the \ HR] formed during Incubation Is
*
determined by pelleting the membranes leaving the f H] In the
supernatant. Disposable mlcrofuge tubes are used so that
radioactivity within the pellet can be determined by cutting off the
tip of the mlcrofuge tube [Gambhlr, 1976; Limbird, 1986].
When utlllzing a single centrifugation of the incubation
suspension, trapping of free radioligand in the pellet can occur,
resulting in high background radioactivity. Washing the pellet to
*
remove trapped free radioligand may effect f HR1 because this complex
will have the opportunity to dissociate during washing. An
alternative to washing, to lower background radioactivity, is to layer
the contents of the incubation above a solution of higher density
(sucrose, oil) in the centrifuge tube. An important determinant as to 
*
whether [ HRl dissociation will occur during the separation technique 
Is the time required for the separation process. Both lowering the 
temperature to 4C to retard dissociation and centrifugation in 
microfuges which can pellet particulate material within 5 seconds, 
minimize r*HR] dissociation during separation.
In vacuum filtration, the bound radioligand is retained on a 
filter while free radioligand passes through the filter. Care must be 
taken in filter selection and filter coating to minimize nonspecific 
absorption of radioligand TLimbird, 19861.
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F. SATURABILITY
To determine whether the radioligand binding sites being examined
are Indeed the physiological receptor* the sites should be
saturable, since a finite density of receptors Is predicted. To
assess saturablllty, the characteristics of binding as a function of
Increasing concentrations of radioligand are determined. When the
*
bound radioactivity [ HR] represents binding to a saturable receptor
A
(possessing a single affinity, K^, for the radioligand [ H]), the plot
* *of [ HR] versus [ H] yields a rectangular hyperbola:
[*HR]
Bound Radioligand
[RJ total
A
H
Free Radioligand
An Important consequence of the fact, a saturation isotherm
A A
plotted as [ HR] versus [ H] Is a rectangular hyperbola. Is that the
horizontal asymptote is the total concentration of receptors (TR] ,
total
or B 1. B will only be attained at infinite concentration of max max
18
*
[H] so ®max may be approached but never attained experimentally 
[Belcher & Bar, 1981; Llmblrd, 1986],
G. SPECIFICITY
Another criteria for binding, which la expected for the
Interaction of the radioligand with the physiologically relevant
receptor, Is that it should demonstrate specificity. The specificity
with which the radioligand interacts with Its binding site Is
determined by competition binding studies, where the Incubation of
receptor-containing preparations with a constant concentration of 
*
radioactivity [ H] is carried out in the presence of increasing 
concentrations of unlabeled competitors such as insulin, prolnsulln, 
desoctapeptlde Insulin and glucagon. Data are plotted as X Specific 
Binding versus L o g ^  Competitor Concentration [Gambhlr, 1976;
Freychet, 1976; Llmblrd, 1986].
1 0 0
X Specific
Binding 50
0
Insulin Proinsulin
EC50 EC50
L o g ^  Competitor Cone.
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The relative potency of a hormone Is expressed as the
concentration of a competitor that reduces specific radioligand
binding detected in the absence of competitor by half (EC^) . When 
*
f H] Is Interacting with the physiologically relevant receptor, the 
order of potency of unlabeled hormone competitors for binding to the 
receptor should parallel the order of potency of these hormones in 
promoting the physiological effect mediated via the receptor.
H. KINETICS
As previously stated, one of the expected criteria for the 
binding of a radiolabeled hormone to the physiologically relevant 
receptor is that the time course of binding should correspond to the 
time-course characteristic of the physiological effect elicited by 
[ H 1. To quantitate the rate of binding of r Hi to its binding site, 
the ratio of radioligand association to and dissociation from the 
receptor is determined.
Specific binding is plotted against time to determine the
k
concentration of bound radioligand at equilibrium ([ H Ieq)* This 
information is then replotted to determine the association rate 
constant (k^). To determine the dissociation rate constant (k^),
k
conditions are fixed so that association of f Hi and [R1 are 
negligable and only dissociation can be measured. Association is made 
negligable by either "infinitely'' diluting the equilibrium solution or 
by adding a large excess of unlabeled competing ligand so that
*
rebinding of the radioligand cannot occur. The L o g ^  of the f HR] at
*
any time/ f HR] at the time dissociation was initiated is plotted
2 0
against time. The slope of this line is determined to be the 
dissociation rate constant (k^).
Since Kp ” k^/k^, the can be calculated from kinetic data and
is equivalent to the determined from saturablllty binding data if 
*
binding of [ Hi to TRl represents binding to a single class of 
receptor, which binds [ H] in a reversible fashion with a fixed 
affinity [Llmblrd, 19861.
I. NON-SPECIFIC BINDING
Specific binding is that binding resulting from the interaction 
of the radioligand with the physiological receptor. However, some 
of the radioactivity detected is actually due to radioligand binding 
to other sites on the membranes, radioligand trapping in the pelleted 
material or non-spec ifically absorbed on filters. This low affinity 
binding is referred to as "non-specific binding" [Belcher & Bar, 1981; 
Freychet, 1976].
Non-specific binding is often defined as that binding which 
cannot be competed for by unlabeled ligand at a concentrat ion 100 X 
of the unlabeled hormone. Another definition of non-specific binding 
is obtained mathematically using computer-assisted analysis. This 
model includes an algebraic description of the radioligand interacting 
with saturable binding sites (specific binding) and a component of 
binding that is non-saturable which increases binding with increasing 
concentrations of radioligand (non-specific binding). Specific 
binding can be obtained by subtracting non-specific binding from total 
binding. fLImbird, 1986].
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J. SCATCHARD ANALYSIS
One of the most frequently used data transformations for 
analyzing radioligand binding Is the so-called Scatchard plot [Weder, 
e£ al^ 1974; Freychet, 1976; Belcher 4 Bar, 1981; Ganmeltoft, 1984; 
Llmblrd, 1986], The advantage of this analysis Is the potential 
ability to estimate receptor density from the x-intercept and receptor 
affinity from the slope of the plot. In actuality, the Scatchard plot 
utilized by most Investigators is actually the Rosenthal modification
of the original Scatchard analysis. The Scatchard/Rosenthal method
* * *
plots [ HR] f H] on the ordinate versus [ HR] on the abscissa or
[B]/[F] versus [B], This is true where B - the concentration of 
radioligand bound in the radlollgand-receptor complex at equilibrium 
and [F] “ the concentration of free radioligand present in the 
Incubation at equilibrium.
From this plot, a linear expression of data can be obtained 
according to the formula y - mx + b where m ” slope and b “ 
x-intercept:
X-intercept - B
tBj
Slope - - Ka - -1/Kp
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Since the negative reciprocal of the slope Is equal to
(Dissociation Rate Constant) the receptor affinity (expressed as K^)
can be obtained.
The x-intercept is an estimate of the total receptor
concentration (B or [R] If n * number of binding sites /
max total °
receptor and you assume that there is 1 binding site per receptor,
therefore n * I, then n * [R1 , estimates fR1 ,. With thetotal total
Rosenthal analysis, the x - intercept is not an actual determination
of total receptor concentration ([RL „ ,) but a determination of the
total
total number of binding sites (n 0 fR] total) fLimbird, 19861.
K. INTERPRETATION OF THE CURVILINEAR NATURE OF THE 
SCATCHARD/ROSENTHAL PLOT
Insulin receptor binding data transformations of fB) /TF“J versus TB1 
are often observed to be curvilinear with an upward concavity. The 
biological interpretations of these findings include the possibilities 
that 1) there are multiple orders of non-interacting binding sites 
with unchanging and dissimilar affinities, 2) multiple affinity states 
of the receptor exist as a consequence of receptor-hormone coupling 
where a variable fraction of the total receptor population is coupled 
to the hormone or 3) negative cooperativity exists where the affinity 
of the overall receptor population decreases with increasing occupancy 
of the receptors. fLimbird, 1986; Gammeltoft, 1984]
Technical problems can also cause the artifactual appearance of 
upward concave Scatchard plots. Artifactual sources Include 11 an
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Inappropriate definition of non-specific binding, 2) the aggregation 
of the ligand at higher concentrations to a dimer or multlmer that 
possess a lower affinity for the receptor and 3) a difference in the 
affinity of kinetic constants of [*H] and fH7 such that the receptor 
possesses a greater affinity for f*Hl than rH], [Pettersson, 1984; 
Limbird, 1986]
Since steady state binding data cannot distinguish between 
multiple, independent populations of receptors possessing unchanging 
affinities for ligands from populations where affinity decreases as 
occupancy Increases, a kinetic approach was developed for an 
Independent assessment of the possibility of negative cooperativity 
among cell surface receptor binding sites fDeMeyts, et a_l, 1973; 
DeMeyts, et al, 1976; Gammeltoft, 1984; Limbird, 1986]. Radioligand 
is Incubated with target membranes unt11 binding reaches steady state. 
This association phase is terminated by "infinite dilution" (usually 
100-fold dilution of the incubation mixture is sufficient'*. Infinite 
dilution prevents further association of radioligand with the receptor 
because the decreased concentration of [*H] and fR] decreases the 
probability of radioligand-receptor interaction.
The rate of dissociation of the radioligand from the receptor is 
monitored over time. To determine whether negative cooperativity 
exists, dissociation is monitored under 2 conditions: infinite
dilution and infinite dilution in the presence of excess unlabeled 
insulin. If the receptor sites bind ligand independently, then the 
filling of unoccuppled receptors with the excess unlabeled insulin 
during the dissociation phase should not alter the rate of 
dissociation of the radioligand. If negative cooperativity among
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receptors exists, the filling of empty receptors with unlabled Insulin
will decrease the overall affinity of the receptor population and
accelerate the rate of radioligand dissociation rDeMeyts, 1973;
Llmblrd, 1986]. The kinetic analysis assumes that Is Independent
of occupancy and suggest that (which equals k£/k^) is Increased due
to an Increase In k^ fGammeltoft, 1984).
DeMeyts proposed a graphic analysis to describe the site-slte
Interactions occurring with negative cooperativity. He developed a
new parameter, the average affinity of receptor sites, K, which is
calculated from (lBl/fF]/R ~[B] where R equals the x-intercept fromo o r
the Scatchard plot (B or n o fR] .). Plotting K as a function ofmax total
fractional occupancy (defined as rB] / .  several observations can be 
made. When binding sites are empty, a limiting high affinity, (K^), 
can be obtained. When 1 to 5% of the sites are occupied, K starts to 
fall until a given level of occupancy (usually 25-50%) is reached 
where a limiting low affinity (K^) is obtained. The plot has been 
termed the "average affinity profile" TDeMeyts, 1975].
The role of ligand-induced regulation of receptor binding 
affinity in vivo is uncertain. At low concentrations, insulin could 
bind to high affinity receptors, which then shift to the low affinity 
state as insulin levels rise. Negative cooperativity could maintain 
insulin sensivitity at low concentrations but attenuate the cellular 
response to higher concentrations and therefore buffer agalnst high 
insulin secretions and reduce oscillations in insulin action. 
rGammeltoft, 1984],
The interpretation of the kinetic phenomena in terms of negative 
cooperativity has been challenged. Evidence to support a 2-receptor
25
model for Insulin binding was found In cultured embryonic heart cells 
[Wheeler, al^ , 1980] . Some researchers contend that the enhanced 
radioligand dissociation at Increasing occupancy Is not definitive 
proof for negative cooperativity [Levitzki, 1981; Gammeltoft, 1984]. 
Binding heterogeneity may be caused by insulin degradation rather than 
negative cooperativity since correction for accumulated radiolabeled 
insulin fragments in liver cells resulted in a linear Scatchard plot 
[Donner, 1980].
Kinetic studies by one group of investigators suggest that there 
are no cooperative interactions between binding sites and that the 
hormone-receptor complex converts to a higher affinity state 
subsequent to occupancy [Corin & Donner, 1982]. The proposed 
mechanism for this 2-state model for the hepatic insulin receptor is a 
conformational change in the receptor [Donner & Yonkers, 1983].
The 2 affinity state model has been revised and extended to
include 3 conformations of high (K ), intermediate (K 1 and low (K,)
s e E
affinltes. The high affinity state (Kg) was found during the 
association of insulin. The altered affinity may result from
removal of regulatory subunits of the receptor that modify binding 
affinity by previously mentioned conformation changes or by positive 
cooperative interactions rGammeltoft, 19841.
Pettersson, et al, found variability in the form of Scatchard 
plots (linear to biphasic) in erythrocyte samples taken from the same 
subjects. These findings support the proposal that an initially 
homogenous class of insulin binding sites, upon exposure to insulin, 
can appear in different forms with different binding affinities for 
insulin. These investigators propose that this could provide an ideal
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means to rapidly regulate erythrocyte response to Insulin [Pettersson, 
e£ al, 19841.
III. TISSUE INSULIN RECEPTORS
Insulin receptor binding has been studied in a variety of tissues 
[Gammeltoft, 1984]. Experimental evidence has accumulated to 
demonstrate that receptors show tissue and species differences in 
functional and structural characteristics. One example of tissue 
difference is the proposed exlstance of "spare receptors" in certain 
tissues, such as fat but not in other tissues, such as liver. The 
spare receptor capacity provides a mechanism for obtaining a rapid 
response at very low concentrations of hormone [Limbird, 1986]. These 
differences may indicate the existence of receptor subtypes that are 
linked to different physiologic actions of insulin [Gammeltoft, 1984],
A. INSULIN RECEPTORS OF HEPATIC TISSUE
The liver's response to insulin stimulation is of major 
importance due to the organ's vital role in glucose and fat 
homeostasis. A single class of receptors with a of 7 X 10 ^  mol* 
1 * was characterized In rat liver membranes fCuatrecasas, et al., 
1971], Other investigators observed 2 classes of receptors with 
values of 5 X 10 ^  and 5 X 10  ^mol* 1 * in rat liver membranes 
[Kahn, e_t ail, 19741 . Studies of isolated rat liver cells found no 
evidence of heterogeneity in kinetic analysis of insulin receptors 
[Gammeltoft, 19781. Receptor mediated degradation of insulin in
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hepatocytes was also demonstrated In this study. Insulin receptors In 
liver cells and membranes have been shown to display moderate negative 
cooperative interactions fDeMeyts, 1976] and up-regulation has been 
demonstrated In rat liver plasma membranes fCorln & Donner, 19811.
B. ERYTHROCYTE INSULIN RECEPTORS
Hepatocytes, adipocytes, monocytes and lymphocytes are the cell 
types frequently used to reflect the Insulin receptor status of an 
organism TPettersson, et al, 19841. Monocytes and lymphocytes have 
frequently been used to study insulin receptor binding in humans 
because of their easy accessablllty fOgunwole, t^^  al_, 1985] and have 
been shown to reflect pathophysiologic states of insulin receptors in 
target t issues TDons , et al_, 1981 ] .
Although the physiological significance of its role as an 
insulin—sensitive cell is not fully established, the erythrocyte has 
been shown to possess specific insulin receptors [Peterson, 19831 and 
is therefore useful in the clinical evaluation of insulin receptor 
status rGambhir, et al, 1978; Ogunwole, et al, 1985; Dons, et al,
1981; Im, et^  al^ , 1983], Erythrocyte insulin receptors have been 
evaluated in normal, obese, diabetic, ketoacidotic and hyperlipidemic 
individuals as well as following fasting, feeding, exercise and 
glucocorticoid treatment. The obvious advantages of the erythrocyte 
are the easy accessability and the small volume of blood (10 ml 
compared to 60 ml for monocytes'* needed for assaying ^Pettersson, e^ 
al, 1985]. Like other cells, specific membrane transport mechanisms 
are present, membrane proteins are specifically organized and present,
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membrane proteins are specifically organized and calcium- dependent 
ATPase activity Is evident TGambhlr, et al, 1978].
Several studles have attempted to compare erythrocyte Insulin 
binding results to those of target tissues obtained simultaneously.
One group of Investigators found a close correlation (r** 0.90) between 
Insulin binding for mononuclear cells and erythrocytes In humans 
TKobayashl, e_t al_t 1980] . Another study correlated insulin receptor 
binding on monocytes with that of erythrocytes (r* 0.62) in humans 
[Ward, et^  al, 1981 ].
A third group of investigators found no significant change in 
Insulin binding with either monocytes or erythrocytes in normal humans 
given 40 mg of prednisone for 3 days rDons, at _al^  1981]. However in 
the same study, when poorly controlled Insulin-dependent diabetics 
were evaluated after improved control, there was a decrease in insulin 
binding for monocytes but not erythrocytes. They concluded that there 
was a general relationship between monocyte and erythrocyte Insulin 
binding but that important differences existed in the way the 
receptors were regulated.
Researchers simultaneously evaluated insulin receptors of 
erythrocytes and hepatocytes of rats with streptozotocin-induced 
diabetes mellitus and found increases in binding for both erythrocytes 
and hepatocytes fOkamato, et stl, 1982]. However, the significant 
Increase in binding of the hepatocytes was due to increases in both 
receptor concentration and affinity, whereas, the increase in binding 
of erythrocytes observed was not significant and due only to increases 
in receptor concentration. They concluded that insulin receptors of 
rat erythrocytes were less sensitive to changes in plasma insulin
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concentrations and that erythrocytes do not always reflect accurately 
the receptor status of hepatocytes.
Two points of controversy arise when deciding that erythrocyte 
insulin binding Is or is not an Ideal model to reflect target tissue 
Insulin receptor binding. The first point of disaggreement concerns 
the ability of the erythrocyte to up or down regulate insulin 
receptors. Because mature erythrocytes lack a nucleus and are not 
capable of de novo protein synthesis, many researchers contend that 
erythrocytes can not up or down regulate insulin receptors [Ginsberg & 
Brown, 1982; Schulz, «jt^ al^ , 1984; Gherzi, e^ al, 19851. Ginsberg, 
al, was unable to demonstrate, in vitro, any significant changes in 
receptor concentrations with mature erythrocytes incubated with 
insulin in contrast to decreased receptor concentrations for 
reticulocytes and primitive nucleated erythrocytes. Gherzi, et al, 
found that mature human erythrocytes were not able to change either 
receptor numbers or affinity after tn vitro preincubation with high 
concentrations of insulin. Both Ginsberg, £t^  al_, and Gherzi, al. 
suggested that clinical studies utilizing erythrocytes be Interpreted 
with caution because of this inability to down regulate Jja vitro and 
that the erythrocyte may only be useful in reflecting chronic changes,
i.e., those that have occurred and been stable during the replacement 
of the entire erythrocyte population.
Schulz found that in vitro studies using supraphyslologic 
concentrations of insulin in the incubation medium showed no 
significant alteration in insulin binding. In contrast, the same 
group of investigators found that in vivo studies involving a 5 hour 
insulin clamp infusion, showed that specific insulin binding to
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erythrocytes decreased (due to affinity) in normal and diabetic 
subjects [Schulz, jrl, 1983]. They concluded that there were 
factors, other than Insulin, which are Involved In the short-term 
regulation of insulin receptor affinity of human erythrocytes and that 
these factors are not effective under vitro conditions. Insel, 
al [1960], also demonstrated down-regulation of Insulin binding to 
monocytes and erythrocytes iji vivo in response to glucose/insulin 
infusions.
Separate studies have suggested that down-regulatlon does occur 
with erythrocyte insulin receptors and that this occurs due to 
receptor Internalization rather than de novo protein synthesis 
[Cambhir, et^  jil^  1981; Peterson, et^  _al_, 1983]. Other researchers have 
also documented acute changes in erythrocyte Insulin binding in vivo 
[Bathena, ^t jQ, 1981; Okuno, et d ,  1983].
A second problem associated with the erythrocyte model is the 
heterogeneity of insulin binding depending on the age of the 
erythrocyte. Tlvarsson & Thorell, 1985], It has been shown that 
insulin binding of erythrocytes is inversely and exponentially related 
to cell age [Dons, et^  ^ 1L, 1981],
When erythrocytes were subjected to density fractionation to 
separate erythrocyte populations according to age, insulin binding 
correlated significantly with pyruvate kinase activity (a well known 
marker for erythrocyte age) and reticulocyte counts [Ivarsson & 
Thorell, 1985; Camagna, et^  al_, 1983]. The correlation was greater for 
pyruvate kinase activity than for reticulocyte counts. However, these 
researchers were unable to show a relationship between insulin binding 
and age-related factors (pyruvate kinase activity and reticuloctye
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counts) in unfractionated samples from individuals with normal 
erythropolesls flnvarsson & Thorell, 19851.
Reticulocytes have been shown to have 10-20 times the insulin 
binding capacity of mature erythrocytes [Peterson, et al^ 1983]. 
However, since reticulocytes compose less than 0.1Z of the total 
erythrocytes population in normal individuals, the reticulocyte 
population would only account for a maximum of IX of the total 
specific insulin binding [Peterson, e^ al^ , 1983],
IV. THE EFFECTS OF GLUCOCORTICOIDS ON INSULIN RECEPTOR BINDING AND 
GLUCOSE TOLERANCE
Insulin resistance was previously defined as a condition where a 
greater than normal amount of insulin is required to achieve a normal 
physiological response. One of the major results of insulin 
resistance is glucose intolerance with resulting hyperglycemia. 
Proposed mechanisms for insulin resistance include insulin receptor 
binding abnormalities, as well as, post-receptor defects lAmatruda,
1985]. A well recognized clinical cause of insulin resistance is 
hypercortisolemia, either endogenously-induced or due to the 
administration of glucocorticoids TElgenmann, 1984; Muggeo, 1983].
The hyperglycemia associated with glucocorticoids may be due to 
increased hepatic gluconeogenesls (due to hepatic insulin resistance) 
as well as decreased glucose utilization in peripheral tissues 
(peripheral insulin resistance) [Amatruda, 1985; Elgenmann, 1984; 
Pagano, e^ ii^ , 1984].
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The effects of glucocorticoids on glucose tolerance have been 
evaluated In dogs with various results depending on steroid 
formulation, dose and duration of administration. Glucocorticoid 
administration In dogs increase hepatic gluconeogenesls [Ninomiya, et 
al. 1975; Tseekutz & Allen, 1972; Hetenyi, ejt **1^  1980; Peterson, t^^  
al, 1986]. Decreased peripheral glucose uptake due to 
glucocortlcold-assoclated insulin resistance is not as well described 
[Ninomiya, et a_l, 1975; Peterson, e_t trl, 1986].
Significant decreased Insulin sensitivity and glucose Intolerance 
occurs in spontaneous canine hyperadrenocorticlsm fPeterson e£ al,
1981; Peterson, 1984; Elgenmann & Peterson, 1984], although 3 weeks of 
1-2 mg/kg of prednisolone resulted in insignificant effects on insulin 
secretion and glucose tolerance in healthy dogs. In this study, the 
only significant effect of glucocorticoid treatment was a mild 
increase in fasting blood glucose concentrations rWolfsheimer, et al,
1986].
An increase in insulin binding to erythrocyte insulin receptors 
was shown In dogs treated with a single IV dose of 1 mg/kg of 
dexamethasone [Dleberg, e£ al_, 1986] .
The effects of glucocorticoids on glucose tolerance, insulin 
sensitivity and insulin receptors have been more extensively evaluated 
in rats [Barton & Passingham, 1980; Olefsky, et al, 1975; Olefsky,
1975; Kahn, e^ a^, 1978; Caro & Amatruda, 1982; Watanabe, £t al_, 1984] 
and humans fAmatruda, e^ j*l, 19851. Various glucocorticoids have been 
evaluated in man, including hydrocortisone TDePirro, £t^  al^ , 1980; 
DePirro, ^t nl, 1981; Yasuda, e_t^ al_, 19821, prednisone rBeck-Nielson, 
e t al, 1980; Canivet, e t a1, 1981; DePirro, et al, 1980; Depirro, et
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al, 1981; Fantua, e_t al_, 1981; Muggeo, et al, 1983; Yasuda & Kitabchi, 
1980; Yasuda, .®i* 1982], prednisolone TKan, el, 1985; Dvenger, 
et al, 1982] and dexamethasone fDePirro, e_t al, 1980; DePirro e^ t al, 
1981; Yasuda & Kitabchi. 1980; Yasuda, et al 1982].
Increases [Fantus, et al, 1981; Kan, at al, 1985] and decreases 
[DePirro, et al, 1980] in maximum binding of Insulin receptors have 
been seen due to glucocorticoids. Increases in the number of receptor 
binding sites have been observed due to glucocorticoids TBeck-Nielsen, 
_et_ al, 1980; Canivet, et aJL, 1983]. Increases fMuggeo, et al, 1983] 
and decreases fDePirro, al, 1981; Yasuda & Kitabchi, 1980; Yasuda, 
et al, 1982] in receptor affinity have been observed due to 
glucocorticoids. Negligible changes in maximum binding, affinity 
and/or the number of receptor binding sites, seen by some researchers, 
suggest an important role for post-receptor defects In the insulin 
resistance seen with glucocorticoids fDvenger, e^ ^ a^ , 1982; Fantus, et 
al, 1981; Nosadinl, et^  al^ , 1983; Rizza, £t^  jil_, 1982; Wajchenberg, et 
al, 1984; Watanabe, £t_ al_, 1984].
Individuals with spontaneous Cushing’s syndrome have shown either 
no change in receptor binding or changes different (increased affinity 
rather than decreased affinity) than subjects administered exogenous 
glucocorticoids rMuggeo, et a^, 1983; Nosadinl, e_t al, 1983; 
Wajchenberg, et al, 1984],
One proposed explanation for the discrepencies seen in various 
studies is that Increases in receptor number or affinity may be caused 
by a direct effect of glucocorticoids, whereas the decreases in 
receptor numbers or affinity may reflect a secondary response to 
Increased circulating Insulin concentrations directly or indirectly
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produced by glucocorticoids (down-regulation) rFantus, ejt trl, 1981;
Rlzza, et al, 1982; Wajchenberg, et al, 1984; Borelli, et al, 1982;
Barseghlan, ^t aQ, 1984],
Changes in insulin receptors observed in association with 
glucocorticoids must be correlated with simultaneous in vivo tests to 
evaluate glucose tolerance and insulin sensitivity in order to 
interpret their physiological significance [Belcher & Bar, 1981; 
Amatruda, et al, 1985].
V. EVALUATION OF INSULIN RECEPTORS IN DOCS
Insulin receptors have been evaluated to a 1imited extent In 
dogs. Insulin receptor binding on lymphocytes was measured in dogs 
with experimentally Induced diabetes mellltus fOrselli & Bouhaddicui, 
1979]. Dogs made diabetic by surgical pancreatectomy had a decreased
number of binding sites on lymphocytes.
Insulin receptor binding was measured as a part of evaluation of 
the glucose Intolerance associated with chronic renal failure In dogs 
with surgically Induced renal failure [Akmal, et al^ , 1985], 
Investigators found no significant difference in binding capacity, 
affinity or binding site concentrations of monocytes from normal dogs, 
dogs with chronic renal failure with parathyroid glands and dogs with 
chronic renal failure without parathyroid glands.
Monocyte Insulin receptor binding was measured in dogs with 
streptozotocin-induced insulin deficient diabetes mellltus 
fBevilacqua, et al, 1985]. There was no significant difference in
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affinity or the number of binding sites in control versus diabetic 
dogs.
Hepatocyte and erythrocyte insulin binding was measured in 
untreated spontaneously diabetic dogs and pancreatectomlzed dogs 
[Church, 1984], The pancreatectomized diabetic dogs showed increased 
maximum specific binding for both hepatocytes and erythrocytes. The 
spontaneously diabetic dogs, which were all hypoinsulinemic, showed a 
wide range of maximum specific binding compared to normal dogs.
Erythrocyte insulin receptors were measured in dogs before and 
after fasting and treatment with dexamethasone TDieberg, et a_l, 1986], 
There was no significant difference in maximum binding after a 72 hour 
fast. The single intravenous administration of dexamethasone (I 
mg/kg) resulted in an increase in maximum binding of insulin which, at 
Day 1 after treatment, was due to an increase in the number of binding 
sites and, at Day 3 after treatment, was due to an Increase in 
affinity.
METHODS
I. INSULIN BINDING ASSAY TECHNIQUES
A. HORMONES
1. RADIOLABELED HORMONE - The radioligand used In all binding studies 
was a purified preparation of homogenous porcine
monolodo[TYR-A14]Insulin generously donated by Dr. Bruce Frank, Lilly 
Research Laboratories Ta] [Frank, et al, 1983], The radioligand used 
was from one of 2 lots having a specific activity of either 308.88 or 
365.00 mlcrocurles per microgram of insulin protein at a concentration 
of 14 mlcrocurles/ ml of Insulin solution.
2. UNLABELED HORMONES - Glucagon was purchased from Sigma Chemical 
Company [b]. Porcine insulin and proinsulin was a generous gift from 
Dr. Bruce Frank, Lilly Research Laboratories [a]Tc1. DesoctapeptIde 
porcine Insulin was a generous gift from Dr. Salvatore Raid, National 
Hormone and Pituitary Program fdl.
B. INSULIN RECEPTORS OF LIVER MEMBRANES
1. LIVER MEMBRANE COLLECTION & PREPARATION - Liver tissue was 
surgically excised from anesthetized dogs. Liver membrane homogenate 
was prepared by a previously described method fBlrnbautner, 19781.
Liver tissue was immediately placed in cold (AC) 0.25 M sucrose 5mM
3 6
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tris buffer (pH 8) [Appendix 1A 7. Approximately 1 gram of liver tissue 
was homogenized with 20 ml of the sucrose buffer with a mechanical 
homogenizer[e], maintaining the tissue in an ice bath (4C) at all 
times. Tissue homogenate was centrifuged [f] in polycarbonate bottles 
at 2500 RPM (500 G) for 15 minutes at 4C. The supernatant was 
collected and centrifuged at 16,000 RPM (20,000 G) for 30 minutes. The 
supernatant was then aspirated and the remaining pellet was resuspended 
In cold (4C) Krebs-Ringers-Phosphate buffer (pH 7.4) (BUFFER L) 
fAppendix IB]. This suspension was centrifuged at 16,000 RPM (20,000 
G) for 30 minutes at 4C. The supernatant was aspirated and the pellet 
was resuspended in 4 ml of Buffer L and frozen in 2 ml aliquots at -20C 
unt11 assayed.
2. PROTEIN DETERMINATION - The protein concentration of the liver 
membrane homogenate was determined by a modification of the Lowry 
method [Lowry, et. jrl* 1951]. Liver membrane homogenate (100 ul) was 
added to 400 ul of distilled water. To this, 3 ml of Lowry Solution 
was added [Appendix 2], After 10 minutes of incubation at 24C, 0.3ml 
of 1 N phenol reagent fb] was added, mixed and Incubated for 30 minutes 
at 24C. Absorbance was read at 750 nm on a spectrophotometer rg n and 
protein concentration was determined from a standard curve using bovine 
serum albumin (concentrations ranging from 50 to 1000 micrograms) as a 
standard.
3. EFFECTS OF PH, TIME AND WASHING ON BINDING - Liver membrane 
homogenate (2ml), prepared and stored according to the previously 
described method, was thawed at 4C and combined with 100 ul of porcine
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monoiodo[TYR-A14]insulin and 6.9 ml of Buffer L. Buffer L was adjusted 
to a pH of 7.0, 7.4, 7.6 and 8.0 in four separate Incubation tubes 
prior to the addition of liver membrane homogenate and radioligand.
The incubation and processing of the liver membrane homogenate and 
radioligand was performed according to modifications of a previously 
described method [Posner, 1974]. The mixture was Incubated in 
triplicate at 24C and the reaction stopped at 0, 10, 20, 30, 60, 120, 
180, and 240 minutes by the addition of 400 ul of the incubation 
mixture to 1.5 microfuge tubes [h] containing 1 ml of cold (4C) Buffer 
L at each pH. Microfuge tubes were centrifuged for 3 minutes in a 
microcentrifuge [i1 and the supernatant was aspirated. Two of the 
triplicate samples were washed a second time with 750 ul of cold Buffer 
L, centrifuged for 2 minutes and the supernatant aspirated. The 
variation in processing of the triplicates of each sample was done to 
evaluate the effects of single versus double washing [Llmbird, 19861. 
All centrifugations and washing procedures were performed in a 4C
refrigerated room. The tips of the microfuge tubes containing the
membrane pellets were cut with a razor blade and placed in 12 X 75 
glass tubes. Each tube was counted for 2 minutes in a gamma counter
rJ ’.
4. EFFECTS OF TEMPERATURE ON BINDING - Liver membrane homogenate (2 ml) 
prepared and stored as previously described, was thawed at 4C and 
combined with 100 ul of porcine monoiodoTTYR-A141 insulin and 6.9 ml of 
Buffer L (pH 7.4). Each incubation mixture (9 ml total volume for each
tube) was incubated at 4C, 15C, 24C and 37C for 3 hours. The
incubation reaction was stopped at 0, 10, 20, 30, 60, 120, 180 and 240
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minutes by the addition of 400 ul of the Incubation mixture In 
triplicate to 1.5 microfuge tubes containing 1 ml of cold (4C) Buffer 
L. Samples were centrifuged for 3 minutes In a microcentrifuge and the 
supernatants were aspirated. 750 ul of Buffer L were added and samples 
were centrifuged for 2 minutes. The supernatants were aspirated and 
the tips of the microfuge tubes containing the membrane pellets were 
cut with a razor blade and placed In 12 X 75 mm glass tubes for 
counting In a gamma counter. All centrifugation and processing was 
performed in a 4C refrigerated room.
5. SATURABILITY OF LIVER MEMBRANE INSULIN RECEPTORS - To assess 
saturabillty, the characteristics of binding as a function of 
increasing concentrations of radioligand were determined. Liver 
membrane homogenate in Buffer L (pH 7.4) (300 ug protein/lOOul) (200 
ul) was incubated with 50 ul of unlabeled porcine insulin (non-specific 
binding) or 50 ul of Buffer L (total binding) and 50 ul of radioligand 
at various concentrations. Radioligand concentrations ranged from 0.5 
to 500 ng/ml. The mixtures were incubated for 3 hours at 15C, then 100 
ul aliquots were added to 1000 ul of Buffer L in duplicate at 4C.
Tubes were centrifuged in a microcentrifuge for 3 minutes and the
supernatants were aspirated. Pellets were washed with 500 ul of Buffer 
L, centrifuged for 2 minutes and the supernatants were again aspirated. 
The tips of the microfuge cubes containing the membrane pellets were 
cut with a razor blade and placed in 12 X 75 glass tubes for counting
in a gamma counter for 5 minutes.
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6 . COMPETITIVE-INHIBITION BINDING WITH VARIOUS HORMONES - Specificity 
of Insulin binding to liver membrane homogenate was demonstrated by 
comparing the effects of various hormones on the binding of porcine 
monolodo[TYR-A14]insulin with the membranes. Radioligand 250 ul were 
added to 5.3 ml of Buffer L (pH 7.4) to formulate the radioligand 
solution. Four ml of liver membrane homogenate were added to 4 ml of 
Buffer L to formulate the membrane solution having a concentration of 
86 ug of protein/lOOul. Hormones for competitive binding included 
porcine insulin, porcine prolnsulin, glucagon and porcine desoctapetlde 
insulin. Each hormone was serially diluted to obtain the following 
concentrations: 10,000, 1,000, 500, 100, 50, 10, 5, 1 and 0 ng/ml. 
Liver homogenate solution (50 ul) 6 unlabeled hormone solution,at each 
concentrationjWere combined with the radioligand solution and incubated 
at 15C. The reaction was stopped after 3 hours by placing the 
microfuge tubes containing the incubation mixtures in an ice bath (4C) 
and adding 500 ul of cold (4C) Buffer L to each tube. The mixture was 
then centrifuged in a microcentrifuge for 3 minutes. Supernatants were 
aspirated, 500 ul of Buffer L were added and tubes were centrifuged 
again for 2 minutes. Supernatants were aspirated and the tips of the 
microfuge tubes containing the membrane pellets were cut with a razor 
blade and placed in 12 X 75 mm glass tubes for counting in a gamma 
counter for 2 minutes.
7. DISSOCIATION OF BINDING - The rate of dissoclation of radioligand 
from liver membrane homogenate was determined in the following manner 
f5). A 115 ul (4.92 ng) aliquot of radioligand was added to 7.385 ml 
of Buffer L (pH 7.4) in tubes "1" and "2" and 7.185 ml of Buffer L and
200 ul (200 ug) of unlabeled Insulin were added to tube "3"
(non-apeclflc binding). This radioligand solution was combined with 
2.5 ml of liver membrane homogenate (86 ug protein/100 ul) giving a 
total volume of 10 ml for each of tubes "1", "2”, "3". The mixture was 
Incubated for 3 hours at 24C and centrifuged for 10 minutes at 7,500 
RPM at 4C. The supernatant was carefully aspirated. The association 
phase was terminated by diluting the Incubation mixture with a volume 
(50 ml) of Buffer L sufficient to prevent rebinding of the radioligand 
(so-called Infinite dilution). The mixture was centrifuged for 10 
minutes at 7,500 RPM (5,400 G1 at 4C. The supernatant was aspirated 
and 10 ml of cold Buffer L (4C) was added to the pellet for 
resuspension. Triplicate samples (400 ul) were taken at 0 time and 
added to microfuge tubes containing 750 ul of cold Buffer L in an ice 
bath (4C) . Next, all Incubation tubes were removed from the 4C ice 
bath, kept at 24C while 200 ul of unlabeled porcine insulin was added 
to tube *'2" (200 ul of Buffer L were added to tubes "1" and "3") and 
timing was started. Triplicate samples (400 ul) were taken from each 
of tubes "I", "2" and "3" at the following times: 5, 10, 20, 30, 60,
120 and 180 minutes. Each sample was added to 750 ul of cold Buffer L 
in an ice bath (4C). All microfuge tubes were centrifuged in a 
microcentrifuge for 3 minutes. Supernatants were aspirated and the 
pellets were washed with 500 ul of cold Buffer L and re-centrifuged for 
2 minutes. Supernatants were aspirated; the tips of the microfuge 
tubes, containing the membrane pellets, were cut with a razor blade and 
placed in 12 X 75 mm glass tubes for counting in a gamma counter for 2 
minutes.
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8 . SCATCHARD ANALYSIS - Calculation of the total number of binding 
sites by Scatchard analysis was determined by constructing complete 
competitive-inhibition curves [4]. The procedure was done in the 
following manner. Fifty ul of liver membrane homogenate in Buffer L 
(pH 7.4) (concentrations ranging from 395 to 458 ug of proteln/100 ul) 
were incubated with 50 ul of radioligand (diluted in Buffer L to a 
concentration of 1-3 ng/ml) and 50 ul of unlabeled porcine insulin 
(diluted in Buffer L to gl ve concentrations of 0 ( 1, 5, 10, 15, 25, 50,
75, 100, 150, 200, 300, 500, 750, 1000, 5000, 10,000 ng/ml) in
triplicate in 1.5 ml microfuge Cubes. The mixtures were incubated for 
3 hours at 15C. At the end of 3 hours all samples were placed in a 4C 
refrigerated room and 750 ul of cold Buffer L was added to all tubes. 
Tubes were centrifuged in a microcentrifuge for 3 minutes and the 
supernatants were aspirated. The pellets were washed with 500 ul of 
Buffer L, centrifuged for 2 minutes and the supernatants were again 
aspirated. The tips of the microfuge tubes containing the membrane 
pellets were cut with a razor blade and placed in 12 X 75 glass tubes
for counting in a gamma counter for 2 minutes.
a. INTERASSAY COEFFICIENT OF VARIATION - To evaluate the interassay 
coefficient of variation of Scatchard analysis binding of insulin 
receptors of canine liver membranes by the previously described method, 
assays were performed on aliquots of the same liver membrane homogenate 
on 5 consecutive days. The assays were incubated for 3 hours at pH 7.4 
at both 15C and 24C.
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9, DEGRADATION OF RADIOLIGAND - In each of the Scatchard analysis 
performed, the percentage of degradation of the radioligand during the 
experiment was determined by trichloroacetic acid (TCA) fl] 
precipitation [Gambhir, et al, 1978], A SO ul aliquot of the 
supernatant obtained after incubation and initial centrifugation, was 
added to I ml of Buffer L and I ml of 10% TCA. This mixture was 
vortexed and centrifuged at 2000 RPM (850 G) [k] for 10 minutes. The 
supernatant obtained was separated from the pellet and each portion was 
counted in a gamma counter to obtain the percentage of radioactivity 
remaining with the insulin protein and the percentage of radioactivity 
separated from the insulin protein (% degradation).
C.INSULIN RECEPTORS OF ERYTHROCYTES
1. ERYTHROCYTE COLLECTION AND PREPARATION - Whole blood was collected 
from healthy dogs by jugular vein venipuncture with a syringe 
containing CPD-AI fm], an anticoagulant/preservative used to collect 
and store canine blood for up to 6 weeks at AC for the purpose of 
transfusion fAppendix 3]. One ml of CPD-AI was added for every 7 ml of 
whole blood and mixed well. The whole blood was refrigerated at AC 
until the time of assay (less than or equal to 5 days), then 
centrifuged at AC for 10 minutes at 1500 RPM (500 G) fk1. Erythrocytes 
were processed by the technique described by Carabhir, et^  jrl, T1978], 
Plasma was aspirated and erythrocytes were resuspended In an equal 
volume of phosphate buffered saline (pH 7.A) (PBS) [Appendix 1C], This 
suspension was then slowly layered over 3 ml of ficoll-hypaque media 
[n] and centrifuged at 1800 RPM (700 G) for 20 minutes at AC.
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The supernatant containing PBS, monocytes, flcoll-hypaque, granulocytes 
and the top portion of the erythrocyte layer were aspirated and the 
remaining erythrocytes were resuspended in 2 parts of PBS. The 
flcoll-hypaque separation was repeated and the supernatant was again 
aspirated. The erythrocytes were resuspended In 10 ml of a Hepes 
buffer (pH 7.6) (Buffer G) [Appendix 1D1 and centrifuged for 10 minutes 
at 1800 RPM (700 G) and 4C. The supernatant was aspirated and Buffer G 
was added to obtain a total volume of 5 ml. The suspension was mixed 
well and placed In an ice bath (4C) until assayed (within 30 minutes).
Erythrocyte concentration of the suspension was determined by 
counting In a hemacytometer [ol. A 25 ul aliquot of the suspension was 
added to 3.8 ml of PBS and 200 ul of 0.4% trypan blue. A 10 ul aliquot 
of this mixture was added to a counting chamber of the hemocytometer,
9
The number of cells counted in 5 square mm boxes was multiplied by 10 
to obtain the number of erythrocytes per ml.
2. EFFECTS OF PH, TIME AND TEMPERATURE ON BINDING - A series of 
experiments varying pH, incubation time and temperature were performed 
to determine the ideal binding conditions for canine erythrocytes.
a. VARIATION IN TEMPERATURE - Total binding tubes were prepared In the 
following manner. Eight ml of Buffer G (pH 8.0) and 200 ul of 
radioligand were combined at 4C and then two ml of this mixture were 
combined with 1 ml of erythrocyte suspension prepared by the previously 
described method. Non specific binding tubes were prepared by adding a 
2 ml aliquot of a mixture of 7.6 ml of Buffer G (pH 8.0), 200 ul of 
radioligand and 400 ul of unlabeled porcine insulin (400 ug) to 1 ml of
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the erythrocyte suspension. Duplicate 100 ul samples, taken from 4 
Identical tubeB (both total and non-specific binding) Intended for 
Incubation at 4C, 15C, 24C, and 37C, were added to cold 400 ul 
microfuge tubes To] containing 100 ul of dibutyl phthalate [p] and 100 
ul of Buffer G (pH 8.0) in an ice bath (4C^ . The 4 temperature tubes 
were then placed In water baths at the appropriate temperature and 
timing started. At 10, 20, 30, 45, 60, 120, 180, 240, 300, 360 
minutes, duplicate 1 0 0 ul samples were taken from all temperature tubes 
(both total and non-specific binding) and added to cold microfuge tubes 
containing dibutyl phthalate and Buffer G as described above.
Microfuge tubes were centrifuged in a microcentrifuge for 2 minutes in 
a refrigerated (4C) room. The supernatants were aspirated and the tips 
of the microfuge tubes containing the erythrocyte pellets were cut with 
a razor blade and placed in 12 X 75 mm glass tubes for counting in a 
gamma counter.
b. VARIATION IN PH AND TEMPERATURE -
1. EXPERIMENT 1 — Erythrocytes were collected and processed as 
previously described. Eight separate assay systems were prepared each 
containing 1 ml of erythrocyte suspension combined with 2 ml of 
radioligand suspension. The erythrocyte suspension was prepared by 
combining 200 ul of moniodo[TYRA14]insulin with 8.0 ml of Buffer G (pH 
8.0) for total binding tubes and 200 ul of monlodoTTYR-A14]insulin with 
7.6 ml of Buffer G (pH 8.0) and 400 ul of unlabeled porcine insulin 
(400 ug) for non-specific binding. Two assay tubes (one for total 
binding and one for non-specific binding) were incubated at each of the 
following temperatures: 4C, 15C, 24C, and 37C. Duplicate samples of
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1 00 ul were removed from each of the eight assay tubes at 0 , 1 0 , 2 0 ,
30, 45, 60, 120, 180, 240, 300, and 360 minutes after combining the 
Incubation mixture. The samples were added to a cold 400 ul microfuge 
tube containing 100 ul Buffer C and 100 ul of dlbutyl phthalate and 
centrifuged for 2 minutes in a microcentrifuge In a refrigerated room 
(4C). The supernatant was aspirated and the tip of the microfuge tube 
containing the pellet was cut and placed In a 12 X 75 glass tube for
counting for 5 minutes in a gamma counter.
2. EXPERIMENT 2 - Erythrocytes were collected and processed as 
previously described. Five separate assay systems were prepared each 
containing 1 ml of erythrocyte suspension combined with 10 ml of Buffer 
G at 5 different pH*s (7.0, 7.4, 7.6, 8.0, 8.4). Ten ul of radioligand 
was combined with 1 ml of Buffer G for each pH. The radioligand
mixture (300 ul) was combined with 600 ul of the erythrocyte mixture
and Incubated for 4 hours at 4C, 15C and 24C. The incubation was 
halted by adding 100 ul duplicated samples to cold microfuge tubes 
containing 100 ul dibutyl phthalate and 100 ul Buffer G and centrifuged 
for 2 minutes in a refrigerated room (4C). The supernatants were 
aspirated and the tips of the microfuge tubes containing the 
erythrocyte pellets were cut and placed in 12 X 75 glass tubes for 
counting in a gamma counter.
3. SATURABILITY OF ERYTHROCYTE INSULIN RECEPTORS
To assess saturability, the characteristics of binding as a 
function of increasing concentrations of radioligand were determined.
200 ul of erythrocyte/Buffer G suspension (erythrocyte count " 4.5 X 
109 cell/ml) was combined with 50 ul of unlabeled porcine Insulin 
(non-specific binding) or 50 ul of Buffer G (total binding) and 50 ul 
of radioligand at various concentrations. Radioligand concentrations 
ranged from 0.5 to 500 ng/ml. Tubes were incubated in an ice bath (4C) 
for 4 hours; then, 100 ul of the samples, in duplicate, were added to 
cold microfuge tubes containing 100 ul of Buffer G and 100 ul of 
dibutyl phthalate. Tubes were centrifuged for 2 minutes in a 
nilcrocentrifuge in a refrigerated room (4C). The supernatant was 
aspirated and the tip of the microfuge tubes containing the pellets 
were cut and placed in 12 X 75 mm glass tubes for counting for 5 
minutes in a gamma counter.
4. COMPETITIVE-INHIBITION BINDINC WITH VARIOUS HORMONES - Specificity 
of insulin binding to canine erythrocytes was demonstrated by comparing 
the effects of various hormones on the binding of porcine
monoiodoTTYRA-14] insulin to erythrocytes. Radioligand (40 ul) was 
added to 1.6 ml of Buffer G (pH 8 ) to formulate the radioligand 
solution. Five ml of erythrocytes were combined with 1 ml of Buffer G 
to formulate the erythrocyte suspension (erythrocyte count =* 8.97 X 10 
9 cells/ml). Hormones for competitive binding included porcine 
insulin, porcine proinsulin, glucagon and porcine desoctapeptide 
insulin. Each hormone was serially diluted to obtain concentrations of
10,000, 5,000, 1.000, 750, 500, 300, 200, 150, 100, 75, 50, 25, 15, 10,
5, 1, and 0 ng/ml. Radioligand (50 ul), unlabeled hormone (50 ul) at 
each concentration and the erythrocyte suspension ( 2 0 0 ul) were 
Incubated for 4 hours at 4C. Duplicate samples of 100 ul were added
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Co cold 400 ul microfuge tubes containing 100 ul of Buffer C and 100 ul
of dlbutyl phthalate and centrifuged in a microcentrifuge in a
refrigerated room (4C) . The supernatants were aspirated and the tips
of the microfuge tubes, containing the erythrocyte pellets, were cut
and placed In 12 X 75 glass tubes for counting for 5 minutes in a gamma 
counter.
5. DISSOCIATION OF BINDING - The rate of dissociation of radioligand
from erthrocytes was determined in the following manner. Radioligand
(150 ul) was added to 2.1 ml of Buffer G (pH 7.6) in tubes "I" and "2".
Radioligand (150 ul), 2.0 ml of Buffer G and 100 ul of unlabeled
porcine insulin (100 ug) were added in tube ”3" (non-specific binding).
The radioligand solution (2.25 ml) was combined with 2.0 ml of
erythrocyte/Buffer G suspension to yield a total volume of 4.25 ml for
each of tubes "1", "2", "3". The mixtures were incubated for 4 hours
at 4C. The association phase was terminated by diluting the incubation
mixture with a volume of Buffer G (50 ml) sufficient to prevent
rebinding of the radioligand. The mixture was centrifuged for 10
minutes at 7,500 RPM (5,400 G) at 4C, the supernatants were aspirated
and 50 ml of cold Buffer G were added to the erythrocyte pellets and
the centrifugation was repeated. Supernatants were aspirated and the
erythrocyte pellets were resuspended with 3 ml of Buffer G. The final
suspension of erythrocytes yielded an erythrocyte count approximately
9
equal to 3.5 X 10 cells/ml for each tube. Triplicate samples (100 ul' 
were taken at 0 time , added to cold microfuge tubes containing 100 ul 
of Buffer G and 100 ul of dibutyl phthalate and centrifuged for 2 
minutes in a refrigerated room (4C). All incubation tubes were removed
4 9
from the 4C ice bath, kept at 15C and 100 ul of porcine unlabeled 
insulin (100 ug) was added to tube "2" (100 ul of Buffer G were added 
to tubes "1" and "3"). Timing was started and at 10, 20, 30, 60, 120, 
180, and 240 minutes triplicate samples ( 1 0 0 ul) were taken from each 
of tubes "1", "2" and ”3" and added to cold microfuge tubes containing 
Buffer G and dibutyl phthalate. The microfuge tubes were centrifuged 
for 2 minutes in a refrigerated room (4C) , the supernatants aspirated 
and the tips of the microfuge tubes, containing the pellets, were cut 
and placed in 12 X 75 glass tubes for counting for 5 minutes in a gamma 
counter.
6. SCATCHARD ANALYSIS - Calculation of the total number of binding
sites by Scatchard analysis was determined by constructing complete
competitive-inhibition curves. An erythrocyte/Buffer G suspension (200
9
ul) (erythrocyte count ■ 4.0 to 6.0 X 10 cells/ml) was combined with 
50 ul of radioligand solution (diluted with Buffer G to a concentration 
of 0.8 to 1.8 ng/ml) and 50 ul of unlabeled porcine insulin (diluted in 
Buffer G to concentrations of 0, 1, 5, 10, 15, 25, 50, 75, 100, 150, 
200, 300, 500, 750, 1000, 5000, 10,000 ng/ml) in an ice bath (4C) for 4 
hours. At the end of the incubation period, 100 ul samples, in 
duplicate, were added to cold microfuge tubes containing 100 ul of 
Buffer G and 100 ul of dibutyl phthalate and centrifuged for 2 minutes 
in a microcentrifuge in a refrigerated room (4C). The supernatant was 
aspirated and the tip of the microfuge tube containing the pellet was 
cut and placed in a 12 X 75 nun glass tube for counting for 5 minutes in 
a gamma counter.
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a. INTERASSAY COEFFICIENT OF VARIATION FOR SCATCHARD ANALYSIS BINDING 
ASSAYS - Based on the results of previously described experiments 
designed to evaluate the effects of variation in pH, temperature and 
incubation times on binding, parallel Scatchard analysis binding assays 
were conducted at pH 7.6 and 8.0 at 4C for 4 hours on the same sample 
of whole blood on 3 consecutive days and again on a second sample of 
whole blood at pH 7.6 for 5 consecutive days. This was done to 
determine: 1) Optimum binding during Scatchard analysis assays and 2) 
to determine the interassay coefficient of variation for the binding 
assays.
7. RADIOLIGAND DEGRADATION - In each of the Scatchard analysis 
performed, the percentage of degradation of radioligand during the 
experiment was determined by TCA precipitation. The supernatant (100 
ul aliquot) obtained after incubation and centrifugation was added to 1 
ml of Buffer G and 1 ml of 10% TCA. This mixture was centrifuged at 
2000 RPM (850 G) for 10 minutes. The supernatant was separated from 
the pellet and each portion was counted in a gamma counter to obtain 
the % radioactivity remaining with the insulin protein (pellet) and the 
X of radioactivity separated from the insulin protein (supernatant) (X 
degradation).
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II. DETERMINATION OF INSULIN RECEPTOR BINDING PARAMETERS FOR A CANINE 
SAMPLE POPULATION
A. ANIMALS
1. HOUSING AND ENVIRONMENT - Twelve healthy mature Beagle dogs frl (6 
males, 6 intact females), ranging In age from 1 to 4 years were used to 
determine the range of values obtained for receptor binding parameters 
In healthy dogs. These dogs were housed outdoors with 2 dogs of the 
same sex placed in each run. The dogs had been housed in the same runs 
for at least 6 months prior to onset of the study. The study was 
conducted from March through May for a period of 6 weeks so that there 
was a change of photoperiod exposure for the dogs during the study.
2. DIET AND WEIGHT - Dogs were fed a constant commercial dry dog food 
fs] [Appendix 4] once daily in the early afternoon. The amount of food 
consumed by the dogs varied from 1 1-21 grams/kg of body weight to 
maintain a constant body weight. The dogs weighed from 10.5 to 14.5 
kg. The average weight change for all dogs during the study was +0.7 
kg with a range of -0.9 to +1.4 kg. Weight changes were less than 5% 
of total body weight in all but 2 dogs which had weight changes of 7.8 
and 9.4% during the study. All dogs were maintained within 10% of 
ideal body weight during the study.
3. MINIMUM DATA BASE - A laboratory minimum data base was performed in 
all dogs to evaluate health. Laboratory evaluation included heartworm
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microfilaria test, complete blood count, urinalysis and biochemical 
profile for serum blood urea nitrogen, creatinine, sodium, potassium, 
chloride, total protein, albumin, alkaline phosphatase, alanine 
transaminase, and aspartate transaminase activity.
a. GLUCOSE TOLERANCE - Glucose tolerance was evaluated by measuring 
serum glucose and insulin concentrations in response to an intravenous 
dose of glucose (500 mg/kg) fFigure P  (Wolfsheimer, et^  al, 1986], All 
blood samples were collected through an indwelling Jugular catheter. 
Samples were taken at 0, 5, 10, 15, 25, 35, 45, 60 minutes to determine 
1) serum glucose concentration in fasting dogB, ill serum insulin 
concentration in fasting dogs, iii) fractional clearance rate of 
glucose, iv) insulin peak response, v) total insulin secreted and vi) 
insulinogenic index. The fractional clearance rate was calculated as 
the slope of the line (0.693/ t 1/2 X 100, as percentage per minute) 
for plasma glucose values taken between 15 and 45 minutes. The insulin 
peak response was considered to be the highest increment of serum 
insulin above the base-line (sample taken before IV glucose) serum 
insulin concentration. Total insulin secretion was estimated as the 
total incremental insulin area above the baseline during the 60 minutes 
of the test. The insulinogenic index was defined as the ratio of 
insulin peak response to the greatest glucose increment above the 
concentration in fasting dogs.
1. SERUM GLUCOSE DETERMINATIONS - Serum samples for glucose 
determination were collected in a clot tube, allowed to clot and
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centrifuged. The serum was removed within 30 minutes. Samples were 
frozen at —20C until glucose determination was performed by a 
spectrophotometrie method rg] using the glucose oxidase method [t]. A 
reference range of canine plasma glucose concentration was determined 
from 26 healthy dogs to be between 80 and 108 mg/dl with a mean of 93.6
(■ 1 SD ■ 8 .6 ) using the same method.
2. SERUM INSULIN DETERMINATION - Serum samples for insulin 
determination were collected in a clot tube, allowed to clot and 
centrifuged. The serum was removed within 30 minutes and frozen at
-20C until assayed. Insulin values for serum samples were determined
by radioimmunoassay, using a commercially available kit for use in 
humans Tu] [Wolfsheimer, e£ al^ , 19861 . Specificity for canine insulin 
was evaluated by demonstrating dilutional parallelism between standard 
solutions commercially provided and serial dilutions of endogenous 
insulin in canine serum. Biological specificity was demonstrated by 
revealing that injected glucose stimulated an Increase in serum insulin 
concentrations in healthy dogs, as well as, by measurement of increased 
insulin concentrations (84 ull'/ml) in a fasted dog with histologically 
confirmed pancreatic B-cell adenocarcinoma. Accuracy was demonstrated 
by the addition of porcine insulin (because the amino acid sequence was 
identical for pore ine and canine insulin and purif led canine insulin 
was unavailable) to canine serum in concentrations from 4 to 200 
ulU/ml. Linear regression analysis of the recovery curve demonstrated 
a correlation coefficient (r) of 0.998. Low-end sensitivity for the 
assay, defined as the apparent concentration 2 SD below the counts at 
maximum binding, was I ulU/ml.
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The lntra-assay precision for 18 replicates of canine serum, with 
a mean concentration of 38.3 ulU/ml, revealed a coefficient of 
variation of 3.7%. The Interassay coefficient of variation for 9 
assays on the same canine serum sample was 13%. The reference range of 
insulin concentrations in canine serum determined from 61 healthy dogs 
of various breeds (31 males and 30 anestral females), was 2.6 to 20.0 
ulU/ml. The means was 7.8 (i 1 SD ■ 3.9).
4. ESTROUS CYCLE EVALUATION IN BITCHES- Cytologic evaluation of 
vaginal epithelium was performed to estimate the stages of the estrous 
cycle for each bitch [Appendix 51. Cotton swabs dampened with sterile
0.9% saline were rotated within the vaginal vault to obtain epithelial 
cells and then the swabs were rolled on a glass slide. Slides were 
stained with a Wright's stain and examined microscopically [91.
Vaginal cytology was examined every 2 weeks for 2 months prior to and 
during the 6 week study. Results of these smears along with physical 
examination of the external genitalia were used to determine stages of 
the estrous cycle for each bitch.
5. HEALTH MAINTAINANCE- All dogs were vaccinated for distemper, 
rabies, leptospirosis, CAV hepatitis, parainfluenza and parvo virus 3 
months prior to onset of the study. Ivermectin [v] was administered 
orally once each month at a dose of 0.05 mg/kg as a heartworm 
preventative and to aid in the control of intestinal parasites. The 
Ivermectin was not administered within 72 hours of any tissue or blood 
sampling. No other medications other than anesthesia were administered 
during the study.
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B. EXPERIMENTAL DESIGN- The 12 dogs were assigned Co 4 groups of 3 
dogs so thac a group of 3 dogs was sampled each week for 6 weeks. Each 
3 dog group contained either 2 males and 1 female or 2 females and 1 
male. Each dog was sampled 3 times at 2 week Intervals. fFigure 21
C. SAMPLE COLLECTION - Dogs were fasted 24 hours prior to sampling. 
Indwelling cephalic catheters were placed and general anesthesia was 
induced by the administration of pentathal sodium [w] at a dose of 11 
mg/kg Intravenously. Dogs were Intubated and anesthesia was maintained 
by inhalation of methophane fx]/02. All dogs were maintained on 
intravenous 0.91 saline at a rate of 2 ml/mlnute for the duration of 
anesthesia which ranged from 45 minutes to 1.5 hours. Whole blood (15 
ml drawn from the Jugular vein into a syringe containing 2 ml of 
CPD-AI) was obtained approximately 10 minutes after the induction of 
anesthesia. This sample was well mixed and stored at 4C until assayed. 
Each blood sample was assayed twice (16 hours later and 64 hours 
later). In 9 of the 12 dogs, on one occasion 7 ml of whole blood was 
drawn from the jugular vein and mixed with 1 ml of CPD-AI prior to the 
Induction of anesthesia. This was done to assess the effects of 
anesthesia on erythrocyte insulin receptor binding.
Liver membranes were obtained by surgical laparoscopy. The 
abdomen was surgically prepped and inflated with either room air, 
nitrous oxide or carbon dioxide with an insuflator placed through a 1 
cm incision off the ventral abdominal midline. Laparoscopy was 
performed by positioning the laparoscope [z] into the abdominal cavity 
through a 2 cm incision, just off the ventral midline approximately 2 
cm cranial to the umbilicus TFigure 31. Visualized biopsy was
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Figure 2. Experimental design for liver tissue and erythrocyte sampling 
of 12 beagle dogs.
Dog Week
3/10/86 4/12/86
1 2 3 4 5 6 7 8 9 10 11 12
1 A B C
2 A B C
3 A B C
4 A B C
5 A B C
6 A B C
7 A B C
8 A B C
9 A B C
10 A B C
11 A B C
12 A B C
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Figure 3a- Surgical laparoscopy for collection of liver tissue from 
a beagle dog.
Figure 3b. Surgical laparoscopy for collection of liver tissue from 
a beagle dog.
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performed with a Storz biopsy forcep [aa] through another 1 cm incision 
off the midline. Eight to 14 pieces of tissue (each weighing 0.1 to
0.2 grams per piece) were harvested per liver biopsy procedure. Tissue 
was placed In cold 0.25 M sucrose, 5mM tris buffer (pH 8.0) In an ice 
bath (4C) and later processed as described in the previous section.
Two aliquots containing 2 ml of liver membrane homogenate were frozen 
at -20C for each sampling.
D. DATA OBTAINED - The following parameters were measured from the 
following samples:
1. SAMPLES: a) 3 samples of erythrocytes taken from each of 12
dogs under anesthesia at 2 week intervals.
b) 1 sample of erythrocytes taken from 9 dogs 30 
minutes prior to anesthesia and collection of 
anesthesized samples.
c) 3 samples of liver membranes taken from 12 dogs 
under anesthesia at the same time of erythrocyte 
collection at 2 week intervals.
2. PARAMETERS MEASURED FROM SCATCHARD ANALYSIS OF EACH SAMPLE:
s') Percentage of maximum binding. This value was
calculated from the sample containing radioligand 
and the receptor suspension with no unlabeled 
insulin.
Total number of receptor sites (per erythrocyte or 
pg of liver protein). This value was calculated
6 1
from the x-intercept (Binax or Ro) of the 
lov-affinity portion (horizontal) of the curve.
c) Number of high-affinity receptor sites. This 
value was taken from the x-intercept (Bmax or Ro) 
of the high-affinity portion (vertical) of the 
curve.
d) High affinity constant (High K^). This value was 
equal to - 1/slope for the vertical portion of the 
curve.
e) Low affinity constant (Low K^). This value was 
equal to - 1/slope for the horizontal portion of 
the curve.
f) Empty- site affinity constant (Ke). This value 
was taken frora the average affinity profile.
E. STATISTICAL ANALYSES- Comparisons of binding data between and 
within liver membranes and erythrocytes were made by Pearson's 
correlation coefficient. The effects of anesthesia on erythrocyte 
insulin receptor binding were evaluated by a Student's paired t test. 
For an estimate of variation of binding parameters for liver membranes 
and erythrocytes within and among dogs, an analysis of variance was 
performed. The effect of sex on binding parameters was evaluated by an 
unpaired t test. Correlations and differences were considered 
significant when p < 0.05.
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III. THE EFFECTS OF GLUCOCORTICOID ADMINISTRATION ON GLUCOSE 
TOLERANCE, INSULIN SECRETION AND ERYTHROCYTE RECEPTOR BINDING IN 6 MALE 
BEAGLE DOGS.
The 6 male dogs were Created with IS mg (1.2S mg/kg) of 
prednisone fbb] orally once daily for 3 weeks. Treatment was initiated 
one to two weeks after their last biopsy sample and given to 3 dogs at 
one time. After 52 hours and 3 weeks, 15 ml of whole blood was drawn 
from the jugular vein and mixed with 2 ml of CPD-A1 and stored at 4C 
until assayed 24 and 72 hours later. An Intravenous glucose tolerance 
test was administered on the same day as the 3 week sampling for 
insulin receptors and parameters evaluated as described previously. 
Identical parameters were measured from the Scatchard analysis of each 
sample as described previously.
Data from the glucose tolerance tests and the erythrocyte insulin 
receptor binding studies taken before and after prednisone 
administration were compared by the Student's paired t test.
Differences were considered significant when p < 0.05.
RESULTS
I. INSULIN BINDING ASSAY TECHNIQUES
A. INSULIN RECEPTORS OF LIVER MEMBRANES
1. COMPOSITION OF LIVER MEMBRANE HOMOGENATE- Protein concentrations 
of the liver membrane homogenates ranged from 100-600 ug/lOOul. 
Electron microscopic evaluation of the liver membrane homogenate 
pellets showed no Intact organelles ^Figure 4]. Matter consisted 
predominantly of disrupted membrane segments. Differentiation between 
plasmalemma and Internal membranes was not possible.
2. EFFECTS OF pH, TIME AND WASHING ON BINDING- For each pH sample 
undergoing either a single or double wash, counts per minute (CPM) 
were plotted against time TFigures 5 & 61. Binding rapidly Increased
over the first 60 minutes of incubation at all pH’s measured. With a
single wash, binding at pH 7 did not reach equilibrium during the 4 
hours of the experiment, while with a double wash, equilibrium 
occurred at 3 hours. At pH 7.4, binding equilibrium did not occur in 
the single wash samples, while with a double wash, equilibrium 
occurred at 3 hours. At pH 7.6, Increasing binding tapered off at 3 
and 4 hours with the single wash and equilibrium occurred at 3 hours 
with the double wash. Equilibrium was not achieved during the 4 hours 
of the experiment in either the single wash or double wash samples at 
pH 8 . At 3 hours, binding was lowest at pH 7.0 (single and double 
wash), almost identical at pH 7.4 and pH 7.6 (single and double wash)
6 3
Figure 4a. Electron microscopy of liver membrane homogenate.
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Figure 4b. Electron microscopy of liver membrane homogenate
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Figure 5
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Rate of binding of monoiodo [TYR-A14] insulin to canine liver 
m embranes at various pH's - single wash ( # d H  = 8.0, O  
= 7.6, A p H  = 7.4, £ p H  = 7.0).
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Figure 6. Rate of binding of monoiodo [TYR-A14] insulin to canine
liver membranes at various pH's - double wash ( # d H = 8.0, 
O  pH = 7.6, A p H  = 7.4, A p H  = 7.0).
68
and either slightly lower (double wash) or higher (single wash) at pH
8.0. Based on these findings, future binding studies were performed 
under the following conditions: 1) Buffer L at pH 7.4, 2) Incubation
time of 3 hours, and 3) washing the homogenate pellet twice.
3. EFFECTS OF TEMPERATURE ON BINDING- For each temperature sample, 
CPM was plotted against time [Figure 7]. During the first 30 minutes, 
binding occurred most rapidly at 37C, then 24C/15C and more slowly at 
4C. Equilibrium occurred at 3 hours at all temperatures. Binding at 
4C occurred more slowly than the higher temperatures but was equal to 
binding at 24c by 3 hours. Binding at 150 and 37C was the same at 
equilibrium and higher than binding at 4C and 240. Based on these 
findings, future binding studies were performed at 15C.
4. SATURABILITY- The bound radioligand [*HR] was plotted against the 
free radiogland [*H] at radioligand concentrations ranging from 0.5 to 
500 ng/ml. The specific binding data was generated by subtracting 
non-specific binding from total binding. The resulting curves are 
shown In Figure 8 . Total binding and non-specific binding curves 
continued to increase In a linear manner with Increasing 
concentrations of radioligand. The specific binding curve began to 
plateau at radioligand concentrations > 50 ng/ml. Although an 
absolutely horizontal portion of the hyperbola was never achieved at 
the concentrations examined, the observed shape of the curve suggested 
that saturation would occur if greater concentrations of radioligand 
had been employed. To confirm this, a double reciprocal plot of 
l/bound insulin versus l/free insulin was constructed. Linear
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Figure 7
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Figure 9. Double reciprical plot of 1/bound insulin versus 1/free 
Insulin for canine liver membranes insulin binding.
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regression analysis of these points yielded a y— intercept » 0.1311 and 
an x-intercept “ -0.0054, supporting the theory that binding sites 
were finite and saturable [Figure 9].
5. SPECIFICITY OF BINDING- The effects of various hormones on 
binding of porcine monoiodo [TYR-A14] insulin to liver membrane 
homogentate Is shown in Figure 10. The percentage of hormone bound 
for each of 4 hormones studied. Unlabeled porcine insulin resulted in 
a competitive—Inhibition curve. The mean concentration of insulin 
that inhibited the binding of the radioligand by SOX (EC^q ) was 
45ng/ml. The mean EC^q for porcine prolnsulln was 300 ng/ml.
Glucagon and porcine desoctapeptlde insulin did not compete 
appreciably with the radioligand for binding on the liver membrane 
homogenate, even at concentrations greater 1 0 0 0 ng/ml.
6 . RATE OF DISSOCIATION- The radioligand bound, shown as percentage 
of initial binding, was plotted against time [Figure 11]. Nonspecific 
binding (tube 3) ranged from 231 to 32X of total binding. Following 
indefinite dilution, dissociation occurred rapidly in tube 2 (infinite 
dilution), binding unexpectedly Increased slightly for the first 15 
minutes, then rapidly decreased in parallel to tube 2. At the 
initiation of dissociation, a great deal of vortexing was required to 
resuspend the liver membranes into solution. While vortexlng was done 
in an ice bath, sufficient heat may have been generated to encourage 
association, in spite of dilution with buffer, and this may have 
accounted for the Increased binding noted initially. Twenty-two 
percent of the binding activity had dissociated by 60 minutes in tube
1 and 421 of the binding activity had dissociated by 60 minutes in
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tube 2. By 3 hours, there was a 38X decrease in tube 1 and 62JE 
decrease In tube 2. In tube 2, empty receptors are filled with the 
excess unlabeled Insulin decreasing overall affinity and accelerating 
the rate of dissociation. The binding characteristic supports the 
phenomenon of negative cooperativlty [Gammeltoft, 1984; Limblrd,
1986].
7. SCATCHARD ANALSYIS- The total number of binding sites was 
determined by the Rosenthal variation of the Scatchard analysis plot 
[Limblrd, 1986]. Radioactivity measured in the sample containing 
1 0 , 0 0 0 ng/ml of unlabeled porcine insulin was considered nonspecific 
binding (NSB) and was subtracted from all other samples to obtain 
specific binding for each concentration. Maximum binding was the 
radioactivity measured in the sample with no unlabeled porcine 
Insulin. The ratio of bound to free radioligand was plotted against 
the concentration of Insulin bound (ng/ml) [Figure 12]. The resulting 
curve was curvilinear in nature with an upward concave configuration. 
When this curve was extrapolated to Its intersecting point on the 
abscissa the total number of receptor sites (Ro) was obtained. High 
affinity and low affinity K^'s were obtained by taking this negative 
Inverse of the slopes of the high affinity (vertical) and low affinity 
(horizontal) portions of the curvilinear line. Results are listed in 
Tables 3A & B.
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Figure 12. Rosenthal/Scatchard Plot of canine liver membrane insulin 
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a. INTERASSAY COEFFICIENT OF VARIATION FOR INSULIN RECEPTOR 
BINDING TO CANINE LIVER MEMBRANES- Interassay coefficient of variation 
(CV) for X maximum binding was 25.OX when the assays were performed at 
15C, pH 7.4 and Incubated for 3 hours. The mean + SEM X maximum 
binding waB 3.87 + 0.43. The Interassay CV for X maximum binding was 
26.IX when the assays were performed at 24C, pH 7.4 and incubated for 
3 hours. The mean + SEM X maximum binding was 2.56 + 0.30.
8 . AVERAGE AFFINITY PROFILE- The data obtained from the Scatchard 
plot was assigned to obtain the average affinity profile according to 
the method of DeMeyts [Figure 13]. Results are listed in Table 3B.
9. RADIOLIGAND DEGRADATION- Degradation of the monoiodo [TYR-A14] 
Insulin was less than 5X in all cases. The X degradation was used to 
obtain a corrected total count for calculation of percentage of 
specific binding for each Individual assay.
B. INSULIN RECEPTORS OF CANINE ERYTHROCYTES
1. ERYTHROCYTE COUNTS- Approximately 4.0 - 6.0 X 109 cells/ml were 
counted In all assays. More than 98X of the cells were viable, as 
determined by the trypan dye exclusion technique [Gambhlr, et al, 
1978). Reticulocyte counts were estimated to be less than 5/500 cells 
counted.
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Figure 13. Average affinity profile for canine liver membrane insulin 
r e c e p t o r s .
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2. EFFECTS OF pH, TIME AND INCUBATION TEMPERATURE ON BINDING-
a. VARIATION IN TEMPERATURE- Binding (measured by CPM In the 
erythrocyte pellet) at all temperatures reached binding equilibrium by 
3 to 4 hours [Figure 14]. Binding was highest at 37C; however, 
hemolysis was noted, as evidenced by a red discoloration of the 
supernatant, after 45 minutes of Incubation. Binding was next highest 
in the 24C, 4C and 15C tubes in that order. Hemolysis was noted In 
the 24c tubwe after 2 hours of incubation and in the 15C tube after 3 
hours.
b. VARIATION IN pH AND INCUBATION TEMPERATURE-
1. EXPERIMENT 1- Binding at pH 8.0, 4C reached an equilibrium 
at 4 hours and was the highest of all groups [Figure 15]. Binding at 
pH 7.6, 4C was next highest and reached equilibrium after 2 hours. 
Binding at pH 8.0, 15C was highest at 2 hours and declined afterwards. 
Hemolysis was noted after 4 hours. Binding at pH 7.6, 15C was the 
lowest and reached equilibrium at 2 hours.
2. EXPERIMENT 2- Binding was highest In samples Incubated at
4C, with the pH 8.0 sample being slightly higher than the pH 7.6
sample [Figure 16]. At 15C maximum binding was highest at pH 7.6 and 
was similar to the 4C, pH 7.6 sample. At 24C maximum binding was at 
pH 8.0; however, hemolysis occurred.
3. SATURABILITY- The bound radioligand [*HR] was plotted against 
free radioligand [*H] at radioligand concentrations ranging from 0.5 
to 500 ng/ml. The specific binding was generated by subtracting non­
specific binding from total binding. The resulting curves are shown 
In Figure 17. Total binding and non-specific binding continued to
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17. Linear saturation isotherm for canine erythrocyte insulin
receptors ( #  Total Binding; O S p e c i f i c  Binding: A  Non-Specific 
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Increase In a linear manner with Increasing concentrations of 
radioligand. The specific binding curve began to plateau at 
radioligand concentrations > 50 ng/ml. Although an absolutely 
horizontal portion of the hyberbola was never achieved at the 
concentrations examined* the observed shape of the curve suggested 
that saturation would occur If greater concentrations of radioligand 
had been employed. To confirm this* a double reciprocal plot of 
1/bound Insulin versus 1/free Insulin constructed. Linear regression 
analysis of these points yielded a y-lntercept ” 0.0461 and x— 
Intercept " -0.0051* supporting the theory that binding slteB were 
finite and saturable [Figure 18 ].
4. SPECIFICITY OF BINDING- The effects of various hormones on 
binding of porcine monolodo [TYR-A14] Insulin to erythrocytes Is shown 
In Figure 19. The percentage of specific binding was plotted against 
the concentration of hormone bound for each of 4 hormones studied. 
Unlabeled porcine Insulin resulted in a typical competltlve-lnhibltlon 
curve. The mean EC^q for porcine Insulin was 10 ng/ml. The mean EC^q 
for porcine prolnsulln was 200 ng/ml. Glucagon and porcine 
deaoctapeptlde on erythrocytes, even at a concentration of 1 0 0 0 ng/ml.
5. DISSOCIATION OF BINDING- The radioligand binding* shown as 
percentage of Initial binding* was plotted against time [Figure 20]. 
Non-specific binding (tube 3) stayed between 10-15Z of total binding 
at all times. Following Infinite dilution* dissociation occurred 
rapidly In both tube 1 (Infinite dilution) and tube 2 (Infinite 
dilution plus excess unlabeled Insulin). Forty— three percent of the
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Figure 18. Double recinrical plot of 1/bound insulin versus 1/free 
insulin for canine erythrocyte insulin binding.
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Figure 19. Co mp e ti t ive-inhibition curves for various hormone ligands
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20. Dissociation of monoiodo[TYR-A14] insulin from canine 
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plus Excess I n su l i n , A  Nonspecific Binding).
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binding activity had dissociated by 1 hour In tube 1 and 56% In tube
2. By 4 hours, 59X and 82t of binding activity had dissociated In 
tubes 1 and 2 respectively. In this experiment, an accelerated rate 
of dissociation was observed In tube 2 with excess Insulin.
6 . SCATCHARD ANALYSIS- The determination of total number of receptor 
sites and K^'s for canine erythrocyte Insulin receptors were done by 
the method described under Scatchard analysis for canine liver 
membranes [Figure 21]. Results are listed In Tables 6A & B.
a. INTERASSAY COEFFICIENT OF VARIATION FOR INSULIN RECEPTOR 
BINDING TO CANINE ERYTHROCYTES- The interassay coefficient of 
variation (CV) for X maximum binding for the 3 day comparison at pH 
7.6. was 4.89 with a mean + SEM of 7.12 0.20. The Interassay CV for
X maximum binding for the 3 day comparison at pH 8.0 was 8.27 with a 
mean + SEM of 8.49 + 0.41. The Interassay CV for X maximum binding 
for the 5 day comparison at pH 7.6 was 9.34 with a mean + SEM of 4.35 
+ 0.18.
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Figure 21. Rosenthal/Scatchard plot of canine erythrocyte insulin 
r e c e p t o r s .
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7. AVERAGE AFFINITY PROFILE— The data obtained from the Scatchard 
plot was analyzed to obtain the average affinity profile by the method 
of DeMeyts [DeMeyts & Roth, 1975] [Figures 22 & 23]. Results are 
listed In Table 6 B.
8 . RADIOLIGAND DEGRADATION— Degradation of monolodo [TYR—A 1A ]
Insulin during the assay was less than 5X in all casu. „ The 
percentage of degradation was used to obtain a corrected total count 
for each Individual assay.
9 1
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Figure 22. Average affinity profile for canine erythrocyte insulin 
r e c e p t o r s .
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Figure 23. Average affinity profiles for canine liver membranes and 
erythrocyte insulin receptors (Doq 3, 3rd samDlinq) {top 
curve - liver membranes; bottom curve - e r y t h r o c y t e s ).
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II. INSULIN RECEPTOR BINDING PARAMETERS OF LIVER MEMBRANES AND 
ERYTHROCYTES FROM A SAMPLE CANINE POPULATION.
A. LIVER MEMBRANES- Within liver membrane data taken from 3 
replicates for 12 dogs, there was a strong correlation between the 
total number of receptor binding sites and the low-affinity rTable
11. There was also a high correlation between the percentage of 
maximum binding and the number of high-affinity receptor binding 
sites. Ke correlated with both the percentage of maximum binding and 
the number of high-affinity binding sites.
There was a moderate inverse correlation between Ke and both the 
low-affinity K^ and the total number of receptor binding sites. There 
was some inverse correlation between the percentage of maximum binding 
and the high-affInity K^.
B. ERYTHROCYTES- Within erythrocyte data taken from 3 replicates for 
12 dogs, there was a moderate correlation between the total number of 
receptor binding sites and the low-affinity Kp as well as between the 
number of high-affinity binding sites and high-affinity rTable 2 ’. 
The percentage of maximum binding correlated with both the number of 
high-affinity receptor binding sites and Ke.
There was an inverse relationship between the percentage of 
maximum binding and the high-affinity . Ke correlated inversely 
with both the total number of receptor binding sites and the 
high-affinity Kp.
Table 1. Correlation Coefficients for Insulin Binding Parameters of Canine Liver Membranes
Comparison r ^  Prob(r
Total Number of Binding Sites vs Low-Affinity 0.83L90 0.0001
X Maximum Binding vs Number of High-Affinity Sites 0.74750 0.0001
% Maximum Binding vs Ke 0.50752 0.0016
Number of High-Affinity Binding Sites vs Ke 0.40858 0.0001
Low-Affinity vs Ke -0.66350 0.0001
Total Number of Binding Sites vs Ke -0.65383 0.0001
X Maximum Binding vs High-Affinity -0.39216 0.0180
Table 2. Correlation Coefficients for Insulin Binding Parameters of Canine Erythrocytes
Comparison r , Prob(r)|r , |/H :f-0) *■--------------------------------------------  0bs ' ' 0bs' O
Total Number of Binding Sites vs Low-Affinity 0.62057 0.0001
Number of High-Affinity Binding Sites vs High-Affinity K^ 0.51170 0.0014
Number of High-Affinity Binding Sites vs X Maximum Binding 0.34318 0.0404
1 Maximum Binding vs Ke 0.31770 0.0590
X Maximum Binding vs High-Affinity Kp -0.46602 0.0042
Total Number of Binding Sites vs Ke -0.44171 0.0070
High-Affinity K^ vs Ke -0.31322 0.0629
vO
Ln
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C. VARIATION IN INSULIN BINDING PARAMETERS IN A NORMAL CANINE 
POPULATION
1. LIVER MEMBRANES- Each binding parameter was evaluated by 
performing an analysis of variance on 3 replicate samples for each of 
the 12 dogs. For the liver membranes, there was no significant 
variation among the 12 dogs for any of the parameters evaluated (Prob 
(a greater F) >0.05) [Tables 3A, 3B & 4], The difference among the 
total receptor site values for male dogs approached significance (Prob 
(a greater F) " 0.0582).
The coefficient of variation (CV) was high for "within dog" and 
"among dog" sampling for liver membranes (Table 5), The lowest CVs 
were In the % maximum binding (29.7-38.4%), high-affinity 
(16.6-26.0%) and the number of high-affinity (25.0-31.1%).
2. ERYTHROCYTES- For the erythrocytes, there were significantly 
higher variation among the 12 dogs than a pooled value representing 
"within dog" variation, for the percentage of maximum binding and the 
number of high-affinity receptor binding sites [Tables 6A, 6B & 71.
The variations among the high-affinity values for the 12 dogs
approached significance (Prob (a greater F) “ 0.0523). When an 
analysis of variance was performed on only the male dogs, there was no 
significantly greater variation among the 6 male dogs than a pooled 
value representing "within dog" variation. When an analysis of 
variance was performed on only the female dogs there was a 
significantly higher variation among the female dogs than a pooled 
value representing "within dog" variation, for the % maximum binding
Table 3A. Insulin Receptor Binding Parameters for Liver Membranes from 12 Dogs
Dogs
% Maximum Binding
Total Number of Receptor 
Sltes/pg Protein
High-Affinity Receptor 
Sites/pg Protein
Replicates A B C A B C A B C
Males
3 10.8 10.4 10.3 156 250 216 73 69 63
5 9.1 6.1 7.2 490 470 165 74 54 44
6 8.7 12.1 12.8 147 229 312 61 90 90
9 7.8 11.1 20.4 284 149 453 71 81 101
10 7.0 11.6 12.8 377 597 488 47 90 69
11 7.6 9.5 15.3 136 162 152 36 103 116
X 10.5 298 74
Females
1 7.1 6.8 8.4 143 359 177 61 51 53
2 10.4 9.8 8.3 190 127 154 72 73 61
4 8.4 4.8 7.4 316 213 413 90 70 62
7 7.5 6.3 20.5 429 321 229 59 65 125
8 9.2 11.9 9.8 207 629 121 76 117 90
12 9.2 9.9 15.0 319 394 494 78 105 107
X 9.5 291 79
Table 3B. Insulin Receptor Binding Parameters for Liver Membranes from 12 Dogs
Dogs
Low Affinity K^, NM High Affinity K^, NM/100 Ke, NM-1
Replicates A B C A B C A B C
Males
3 0.395 0.714 1.044 5.590 5.600 6.050 1.073 0.539 0.540
5 1.970 2.703 0.605 4.960 6.680 4.960 0.310 0.183 0.521
6 0.323 0.499 0.713 5.710 6.170 6.470 0.936 0.718 0.480
9 1.157 0.340 1.372 7.198 8.690 3.317 0.366 0.731 0.756
10 1.155 3.338 0.775 4.735 5,162 2.694 0.233 0.329 0.464
11 0.347 0.300 0.116 5.347 7.079 4.306 0.608 0.926 1.675
X 1.070 5.584 0.633
Females
1 0.410 0.573 0.595 5.780 5.190 5.460 0.747 0.275 0.567
2 0.447 0.221 0.516 4.860 5.840 6.130 0.867 1.048 0.629
4 1.076 0.644 2.114 6.770 6.860 5.990 0.484 0.457 0.271
7 1.308 2,203 0.343 5.639 7.224 4.381 0.224 0.241 1.324
8 0.685 2.665 0.220 6.662 9.119 7.366 0.562 0.224 1.028
12 1.246 1.072
00 7.246 7.179 4.735 0.368 0.382 0.471
X 1.005 6.243 0.565
Table 4. Analysis of Variance of Insulin Receptor Binding Parameters from Liver Membranes of 12 Dogs*
^Maximum
Binding
Total Number of 
Receptor Sites 
/pg Protein
High Affinity 
Receptor Sites 
/pg Protein
Low Affinity
V  m
High Affinity 
Kjj, NM/100 Ke, NM-1
Male Dogs 
MS Within Dogs 
MS Among Dogs
13.013
9.772
13,487
39,714
513
364
0.714
0.910
2.109
1.747
0.090
0.226
r MS Among 
* MS Within
0.75 2.94 0.71 1.27 0.83 2.52
Prob (a greater F) 0.6011 0.0582 0.6280 0.3367 0.5534 0.0882
Female Dogs 
MS Within Dogs 
MS Among Dogs
13.232 
11.440
19,358
22,257
385
762
0.547
0.547
1.070
2.098
0.113
0.081
r  ^MS Among 
" MS Within
0.86 1.15 1.98 1.00 1.96 0.72
Prob (a greater F) 0.5321 0.3874 0.1542 0.4578 0.1574 0.6235
Overall
MS Within Dogs 
MS Among Dogs
13.123
10.606
16,422
30,985
449
563
0.630
0.728
1.590
1.923
0.101
0.153
MS Among 
* MS Within
0.81 1.89 1.25 1.16 1.21 1.51
Prob (a greater F) 0.6233 0.0983 0.3091 0.3655 0.3337 0.1951
* 6 males, 6 females, each dog sampled 3 times;
** MS = mean square
Table 5. Coefficients of Variation (CV) for Insulin Receptor Binding Parameters for Liver Membranes of 12 
Dogs*
ZMaximum
Binding
Total Number of 
Receptor Sites 
/pg Protein
High Affinity 
Receptor Sites 
/pg Protein
Low
Affinity
V  “*
High
Affinity
NM
100
Ke, NM-1
Male Does
Within Dog 34.3 39.0 30.6 79.0 26.0 47.3
Among Dog 29.7 67.0 25.8 89.1 23.7 75.0
Female Does
Within Dog 38.4 47.8 25.0 73.6 16.6 59.5
Among Dog 35.7 51.3 35.1 74.0 23.2 50.3
Overall
Within Dog 36.2 43.6 27.8 76.5 21.3 53.1
Among Dog 32.6 59.9 31.1 82.2 16.9 65.3
*6 males, 6 females, all dogs sampled 3 times. 
Expressed as %.
Table 6A. Insulin Receptor Binding Parameters for Erythrocytes from 12 Dogs
Dogs
X Maximum Binding
Total Number of Receptor 
Sltes/RBC
High-Affinity Receptor 
Sltes/RBC
Replicates A B C A B C A B C
Males
3 7.1 A.8 7.2 119 206 355 21 29 30
5 3.7 A.2 6.7 18A 193 127 25 22 20
6 3.2 5.6 5.0 110 250 274 20 30 35
9 A.5 3.8 A.7 303 70 176 23 24 27
10 6.8 5.3 5.8 86 15A 131 33 47 32
11 6.6 A.8 5.8 158 375 101 A9 27 39
X 5.3 *187 29
Females
1 3.5 5.5 8.5 205 220 162 15 23 32
2 A.2 2.6 A.8 170 37 5AA 1A 15 20
4 6.2 A. 1 6.1 All 238 AA3 27 18 32
7 3.0 3.A 5.2 291 128 57 26 29 21
8 7.0 7.1 9.5 529 166 3A5 41 39 AA
12 2.8 5.0 3.7 332 155 23A A3 30 55
X 5.1 *259 29
* p = 0.0779
10 
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Table 6B. Insulin Receptor Binding Parameters for Erythrocytes from 12 Dogs
Dogs
Low Affinity NM High Affinity 1^, NM/100 Ke. NM-1
Replicates A B C A B C A B C
Males
3 0.954 1.404 1.955 3.208 3.868 3.074 0.532 0.509 0.284
5 2.385 0.994 1.994 5.350 3.950 2.398 0.315 0.405 0.597
6 1.279 1.228 1.850 4.836 3.853 6.168 0.416 0.667 0.409
9 1.066 0.444 1.480 2.752 4.427 4.092 0.423 0.792 0.447
10 0.456 1.464 0.454 2.561 6.433 3.289 1.439 0.529 0.733
11 1.008 4.793 0.427 4.135 4.621 5.461 0.812 0.308 0.640
X 1.424 4.137 0.570
Females
1 4.104 2.443 1.016 4.040 3.606 2.722 0.181 0.442 0.847
2 3.413 0.340 5.809 4.330 5.185 2.471 0.231 0.957 0.116
4 7.348 5.917 2.584 3.540 3.171 3.907 0.342 1.561 0.189
7 2.439 0.792 0.430 3.986 6.547 2.954 0.180 0.341 1.186
8 1.877 0.926 2.775 2.859 4.469 3.510 0.438 0.572 1.105
12 1.452 0.763 2.087 7.428 4.885 11.417 0.181 0.438 0.262
X 2.584 4.501 0.531
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Table 7. Analysis of Variance of Insulin Recepter Binding Parameters from Erythrocytes of 12 Dogs*
ZMaximum 
Binding
Total Number of 
Receptor Sites 
/pg Protein
High Affinity 
Receptor Sites 
/pg Protein
Low Affinity High Affinity 
K^, NM/100 Ke, NM" 1
Male Dogs 
MS Within Dogs 
MS Among Dogs 
MS Among 
” MS Within
1.281 
2.074 
1.62
9835
4287
0.44
47
134
2.83
1.185
0.687
0.58
1.530
1.079
0.71
0.066
0.089
1.35
Prob (a greater F) 0.2285 0.8152 0.0648 0.7158 0.6307 0.3103
Female Dogs 
MS Within Dogs 
MS Among Dogs
2.296
7.651
22,896
19,890
3.513
3.38
3.053
6.815
2.905
8.811
0,220
0.076
MS Among 
= MS Within
3.33 0.87 6.63 2.23 3.03 0.35
Prob (a greater F) 0.0406*** 0.5296 0.0035*** 0.1181 0.0535 0.8756
Overall
MS Within Dogs 
MS Among Dogs
1.788
4.862
16,366
12,089
49
236
2.120
3.751
2.218
4.945
0.143
0.083
MS Among 
MS Within
2.72 0.74 4.80 1.77 2.23 0.58
Prob (a greater F) 0.0217*** 0.6823 0.0008*** 0.1220 0.0523 0.8165
* 6 males, 6 females, each dog sampled 3 times; 
** MS - mean square 
***Significant
103
104
and the number of high—affinity binding sites. The differences among 
the total receptor site values for females approached significance 
(Prob (a greater F) - 0.0535). These findings would suggest that 
there was more variation among females than among males.
In addition, mean squares of each binding parameter for males and 
females were compared. Results of this analysis of variance showed 
that there was a greater "among dogs" variation in females compared to 
"among dogs" variation in males that was significant for low-affinity 
and high-affinity far erythrocytes.
The CVs were high for both "within dog" and "among dog" sampling 
of erythrocytes [Table 81. The lowest CVs were in the X maximum 
binding (21.3 - 54.0%), the number of high affinity receptor sites 
(23.0 - 63.7%) and the high—affinity (25,1 — 66.0%). The higher 
CVs occurred in female dogs as compared to male dogs. As previously 
mentioned, the difference In variation was significant for "among 
dogs" for the overall population as well as for females for the % 
maximum binding and the high-affinity binding sites. The variation 
occurring "within dogs" was less than the variation "among dogs".
D. THE EFFECTS OF SEX ON INSULIN RECEPTOR BINDING PARAMETERS
When Insulin receptor binding parameters for liver membranes were 
compared according to sex by an unpaired t test, there were no 
significant differences between males and females for any of the 
parameters [Tables 3A, 3B &4],
Table 8. Coefficients of Variation (CV) for Insulin Receptor Binding Parameters for Erythrocytes of 12
Dogs*
XMaximum
Binding
Total Number of 
Receptor Sites 
/RBC
High Affinity 
Receptor Sites 
/RBC
Lov
Affinity
V  ^  
U 100
High
Affinity
V  ™ Ke, NM" 1
Male Dogs
Within Dog 21.3 53.0 23.5 76.5 29.9 45.2
Among Dog 27.1 35.0 39.5 58.2 25.1 52.4
Female Dogs 
Within Dog 29.6 58.4 24.7 67.6 37.9 88.3
Among Dog 54.0 54.5 63.7 101.0 66.0 51.9
Overall
Within Dog 25.6 57.4 24.1 72.7 34.5 68.7
Among Dog 29.5 49.3 53.0 96.8 51.5 52.2
*6 males, 6 females, all dogs sampled 3 times. 
Expressed as X.
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When erythrocyte binding parameters were compared according to 
sex by an unpaired t test, no significant differences between males 
and females were observed [Tables 3A, 3B &4]. Insignificant Increases 
in the total number of binding sites ( p- 0.0779), low-affinity ( p 
■ 0 .1 2 2) and high-affinity Cp “ 0.640) were observed for females.
As previously mentioned CVs for both "within dog" and "among dog" 
comparisons were high for both liver membranes and erythrocytes 
[Tables 5 & 8 ]. This degree of variation might have masked the 
presence of significant differences in binding parameters between the 
sexes.
E. LIVER MEMBRANES VERSUS ERYTHROCYTES - Insulin receptor binding 
parameters of liver membranes and erythrocytes were compared by 
Pearson's correlation coefficient. There was no significant 
correlation between the percentage of maximum binding, the total 
number or the number of high-affinity binding sites, low or 
high-affinity or Ke, when all 12 dogs were compared. The same was 
true when male dogs were compared; however, when female dogs were 
compared, there was a correlation between liver membrane and 
erythrocyte Ke values (r " 0.47610, p “ 0.0458).
As previously mentioned, CVs for both "within dogs" and "among 
dog" comparisons were high for both liver membranes and erythrocytes 
[Tables 5 & 81. This degree of variation might have masked the 
presence of significant correlations.
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F. THE EFFECTS OF ANESTHESIA ON ERYTHROCYTE INSULIN RECEPTOR BINDING
In 9 dogs, erythrocyte Insulin receptor binding was measured
prior to anesthesia [Table 9]. When compared to samples taken during 
anesthesia, by a paired t test, the percentage of maximum binding was 
significantly Increased from a mean of 3.96 to 5.28 ( p* 0,028),
There were insignificant increases in the total number and 
high-affinity receptor sites (p -  0.1780 total sites; p - 0.1037 
high-affinity sites). An insignificant decrease in affinity, as 
indicated by an Increase In the low-affinity value and a decrease
In the Ke value was observed ( P“ 0,306 low-affinity K^; p = 0.260
Ke) .
III. THE EFFECTS OF GLUCOCORTICOIDS ON GLUCOSE TOLERANCE, INSULIN 
SECRETION AND ERYTHROCYTE INSULIN RECEPTOR BINDING IN 6 MALE BEAGLE 
DOGS
A. GLUCOSE TOLERANCE- The effect of prednisone administration on 
glucose response to 500 mg of intravenous gtucose/kg of body weight 
is shown in Figure 24 and Table 10, Mean serum glucose concentration 
in fasting dogs was insignificantly increased after prednisone 
administration for 3 weeks (0.10> P >0,05). There was an increase 
in mean serum glucose concentrations at 5, 10, 15, 25, 35, 45 and 60 
minutes after glucose administration; however, the Increases were not 
significant ( p >  0.10). Mean disappearance rate (K) was not different 
after prednisone administration.
Table 9. The Effects of Anesthesia On Erythrocyte Insulin Receptor Binding
Dog Replicate
XMaximum
Binding
Total Number of 
Receptor Sites 
Per RBC
High-Affinity 
Receptor Sites 
Per RBC
Low-Affinity 
Kj,. NM
High-Affinity
K^, NM/100 Ke, NM-1
Before During Before During Before During Before During Before During Before During
4 C 2.24 6.09 14 443 14 31 0.072 2.594 7.237 3,907 1.608 0.189
5 C 4.09 6.73 164 127 18 20 2.711 1.994 4.310 2.398 .239 0.597
6 C 3.23 4.98 98 274 24 35 0.699 1.850 4.938 6.168 .482 0.409
7 B 3.59 3.44 17 128 17 29 0.040 0.792 3.955 6.547 2.689 0.341
8 B 7.03 7.07 111 166 36 39 0.184 0.926 3.335 4.469 .840 0.572
9 B 4.61 3.81 161 70 23 24 0.548 0.444 2.843 4.427 .450 0.792
10 C 5.02 5.83 109 131 50 32 0.488 0.454 7.957 3.289 .557 0.733
11 C 4.U 5.85 69 101 15 39 0.439 0.427 2.803 5.461 .863 0.640
12 C 1.72 3.71 247 234 22 55 2.950 2.087 7.966 11.417 .133 0.262
Mean 3.96** 5.28** 110 186 24 34 0.903 1.285 5.038 5.343 0.873 0.504
SE 0.52 0.45 25 39 4 3 0.372 0.281 0.711 0.879 0.269 0.071
*A11 values obtained from sample taken during anesthesia represent the mean of 2 duplicate assays. 
**P < 0.05
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Figure 24. Serum glucose concentrations in 6 m a le  beagles, before and 
after administration of 1.5 mg prednisone/kg orally each 
day for 3 weeks, during IV qlucose tolerance tests (500 
mg/kg glucose) (Mean + SEM, mg/dl , #  Before Treatment,
O Af te r Treatment).
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Table 10. Effects of Prednisone on Glucose Concentrations During an 
IV Glucose Tolerance Test In 6 Male Beagle Dogs.
Dog No. Fasting Glucose mg/dl Clearance Rate (X/mln)
Before After Before After
1 104 2.89
2 99 3.55
**3 108 1 2 0 2.61 2.26
4 93 3.09
**5 96 102 2 . 2 0 2.44
* * 6 104 105 2.74 2.39
7 81 2.38
8 76 2.59
**9 84 8 6 3.64 3.16
* * 1 0 73 94 6.25 2.82
* * H 6 8 103 2.69 2.50
12 62 3.26
X + SEM
N - 12 87 . 3±4.5 3.16+0.31
N * 6 treated
males 8 8 .8 ±6 .7* 101.7+4.7* 3.36+0.61 2.60+0.14
* P < 0.10
** Males
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B. INSULIN SECRETION- The effect of prednisone administration on 
insulin secretion in response to 500 mg of Intravenous glucose/kg of 
body weight is shown in Figure 25 and Table 11. Mean serum insulin 
concentrations in fasting dogs was not significantly different after 
prednisone administration compared to before treatment in the 6 male 
dogs. The Insulin peak response (IPR), total insulin secretion (TIS) 
and lnsullnogenic index (AI/AG) did not show a difference with 
prednisone treatment. Mean Insulin concentrations at 5, 10, 15, 25, 
35, 45, and 60 minutes after glucose administration were not 
significantly different after the administration of prednisone.
C. BODY WEIGHT - The effect of prednisone administration on body 
weight is shown in Table 12. There was a significant (p<0.00 
decrease in mean body weight after 3 weeks of prednisone 
administration when the amount of dog food fed and consumed was kept 
exactly the same. All dogs lost weight and that weight lost ranged 
from 0.4 to 1.8 kg/dog. Six females who were not given prednisone 
were also evaluated for changes in weight during this period. There 
was not a significant change in body weight for this group of dogs.
D. INSULIN RECEPTORS— Insulin receptors binding parameters of canine 
erthyrocytes that were measured 52 hours and 3 weeks after the onset 
of daily prednisone administration were compared to unanesthetized 
samples taken prior to administration of prednisone f5C, 6C , 9B, 10C
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Figure 25. Serum insulin concentrations in 
and after administration of 1.5 
each day for 3 weeks, durinq IV 
(500 mg/kg glucose) (Mean ± SEM 
Treatment, O A f t e r  Treatment).
6 ma le  beagles, before 
mg prednisone/kg orally 
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Table LI. Effects of Prednisone on Insulin Secretion During an IV 
Glucose Tolerance Test In 6 Male Beagle Dogs.
Insulin in Insulin Total Insulin Insullnogenlc
Fasting Dogs Peak Response Secretion Index
Dog No. ( IU/rol) ( IU/ml) ( IU/ml/min) ______________
Before Af ter Before After Before After Before Af te
1 5.4 62.8 216.3 0.325
2 6 . 6 67.8 209.9 0.353
**3 7.7 7.5 43.9 11.9 132.3 39.6 0.252 0.062
4 5.1 24.9 72.2 0.126
**5 1 2 . 0 6 . 6 20.5 13.7 71.5 6 6 . 0 0.099 0.062
* * 6 1 2 . 0 12 . 1 54.3 46.4 155.5 152. 7 0.289 0.230
7 4.9 72.2 228.6 0.363
8 5.6 22.5 67.5 0. 114
**9 4.7 8 . 0 33.4 38.3 122. 7 109.5 0.118 0.191
* * 1 0 8.5 13.9 41.4 41.5 123.2 108.4 0.290 0.284
* * 1 1 12.1 1 1 . 0 30.3 79.3 111.7 266.9 0. 159 0.493
12 3.5 15.4 133.8 0.249
X+l SEM
N-12 7.3+0.9 40.8± 
5.6
137.0+
16.2
0.228± 
0.029
N-6
treated
9.5 + 1.2 9.9 + 
1.2
37.3+
4.8
38.9+
10 . 2
119.5± 
11.3
12 3.9± 
32.8
0 .2 0 1 +
0.035
0 .2 2 0 :
0.066
males
**Males
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Table 12. Effects of Prednisone on Body Weight of 6 Male Beagle Dogs 
Compared to 6 Untreated Female Dogs During the Same Time 
Period.
____________Body Weight, Kg_____________
Dog No. Before After
1 11. I
2 10.5
**3 11.1
4 11.1
**5 12.0
* * 6 12.3
7 11.8
8 12.3
**9 12.7
**10 12.7
**11 14.1
12 11.4
X ± 1 SEM
N - 1 2  11.9+0
N - 6 females 11.4f0
N - 6 treated males 12.5tO
* p < 0 . 0 1
**Males
11.4
10.5 
1 0 . 0  
1 1 . 8  
10.7
10.5
1 1 . 6  
11.1 
12.3 
1 1 . 6  
13.0 
10.9
.3 11.3+0.2
.3 11.2+0.2
.4* 11.4+0.5*
1 1 5
and 11C; unanesthetized sample of 3C lost) by a paired t test (Table 
13]. After 52 hourB, there was an Insignificant Increase In the 
percentage of maximum binding from a mean of 4.2% to 6.45% (0.10 > P > 
0.05). There were Increases in the total number and high-affInity 
receptor sites, although the increases were not significant (p > 
0.10). Slight changes In affinity were conflicting and not 
significant (decreased affinity as evidenced by an Increase In 
low-affinity K^ and an increased affinity as evidenced by an increase 
In the Ke and a decrease in high-affinity K^) (p >0.10). -
There were no significant changes in any binding parameters 
measured after 3 weeks of prednisone administration. There was an 
insignificant increase in the total number of receptor sites and an 
insignificant increase in the low-affinity K~ value (p > 0 ,1 0).
Table 13a. The Effects of Prednisone on Erythrocyte Insulin Receptor Binding in Male Dogs*
Dog
^Maximum
Binding
Total Number of 
Receptor Sites 
Per RBC
High-Affinity 
Receptor Sites 
Per RBC
Before 52 HR 3 WKS Before 52 HR 3 WKS Before 52 HR 3 WKS
3 5.17 7.13 43 63 23 33
5 4.09 4.06 3.10 164 55 127 18 16 27
6 3.23 3.14 3.57 98 330 286 24 24 13
9 4.61 8.28 7.20 161 135 149 23 33 40
10 5.02 9.35 3.77 109 357 51 50 54 17
11 4.11 7.43 3.50 69 56 119 15 38 18
N=6 X 6.24 4.71 162.7 132.5 31.3 24.4
SE 1.01 0.78 64.3 34.4 5.5 4.3
N=5 X 4.21** 6.45** 4.23 120.2 186.6 146.4 26.0 33.0 23.0
SE 0.30 1.21 0.75 18.4 65.7 38.5 6.2 6.5 4.8
*A11 values expressed as mean of duplicate samples assayed. "Before" samples taken from unanesthetized 
samples taken during main study. "52 HR" Samples taken 52 hours after the onset of administering 
prednisone orally each day. "3 WKS" Samples taken 3 weeks after the onset of administering prednisone 
orally each day.
** p < 0 ,10.
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Table 13b. The Effects of Prednisone on Erythrocyte Insulin Receptor Binding in Male Dogs*
Dog
Low Affinity
V  m
High Affinity 
Kp, NM/100 Ke, NM-1
Before 52 HR 3 WKS Before 52 HR 3 WKS Before 52 HR 3 WKS
3 0.330 0.431 4.257 4.212 1.213 1.443
5 2.711 0.650 1.040 4.310 4.329 7.450 0.239 0.665 0.347
6 0.699 2.061 4.889 4.938 4.863 3.385 0.482 0.148 0.190
9 0.548 0.741 0.990 2.843 2.804 4.754 0.450 0.901 0.839
10 0.488 3.487 0.636 7.957 4.521 3.836 0.557 1.981 0.889
11 0.439 0.328 1.042 2.803 4.014 3.165 0.863 0.352 0.545
N=6 X 1.266 1.504 4.131 4.467 0.877 0.709
SE 0.516 0.684 0.290 0.640 0.270 0.184
N=5 X 0.977 1.453 1.719 4.570 4.106 4.518 0.518 0.809 0.562
SE 0.436 0.587 0.795 0.941 0.353 0.781 0.101 0.319 0.136
♦All values expressed as mean of duplicate samples assayed. "Before" samples taken from unanesthetized 
samples taken during main study. "52 HR" Samples taken 52 hours after the onset of administering 
prednisone orally each day. "3 WKS" Samples taken 3 weeks after the onset of administering prednisone 
orally each day.
DISCUSSION
I. ASSAY TECHNIQUES
The use of porcine Insulin (both labeled and unlabeled) Is Ideal 
for studies In the dog since the amino acid sequence of insulin Is 
Identical In these 2 species fGanong, 1985]. The fact that structure 
is identical is very Important for immunoreactlvlty in the case of 
radioimmunoassays [Relmers, et al, 1982]. Structural similarity is 
also of Importance for radlo-receptor Interactions as evidenced by 
competitive-inhibition curves using insulin with similar but different 
structures (prolnsulln, desoctapeptlde insulin, guinea pig insulin, 
chicken insulin) [Cambhir, et al, 1978; Posner, 1974]. The decreased 
binding by prolnsulln and desoctapeptlde insulin in
competitlve-inhibition curves In this study supports the importance of 
structural similarity in radio-receptor studies fFigures 10 & 19].
Monoiodo[TYR-A14]insulin was used in this study due to its 
previously described ideal bioactivity and binding affinity fFrank, £t 
al, 1983], Even though this radioligand has been reported to be 
stable for 6 months the radioligand was only used for a maximum of 3 
months after preparation (stored at 4C). This decision was made due 
to an observed irregularity in duplicate sample counts in assays 
conducted using older radioligand and the reported concerns about 
decreases in the apparent number of binding sites fMattinen, et al, 
1984],
The conditions for assaying canine liver membrane insulin 
receptors used were similar to previously reported conditions (buffer
1 1 8
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content* pH & temperature) [Posner, 1974]. The assay conditions for 
canine erythrocytes used varied significantly from assay conditions 
Initially described fGatnbhlr, et al, 1978; Dleberg, et al, 1986] but 
utilized a similar incubation temperature reported for erythrocyte 
receptor assays [Pettersson, et al, 1984].
The rationale for varying the previously described temperature 
from ISC to 4C and the previously described pH from 8.0 to 7.6, was to 
maximize binding while minimizing erythrocyte hemolysis. Previous 
studies have shown an increase in hemolysis of canine erythrocytes as 
the pH was Increased [Glger, et al, 1985], The results of this study 
showed that at 4 hours, hemolysis was not present at pH 7.6, whereas, 
at pH 8.0 it routinely occurred TFigures 14-161.
Other studies have shown that the occurrence of hemolysis in 
radioreceptor assays of erythrocytes may decrease binding by as much 
as 25% [Simionescu, et al, 1985] . In the present study, hemolysis 
actually Increased binding when performed at 24C and 37C up to a 
point. This could have been due to binding by Intracellular receptors 
or non-insulin receptor binding in hemolyzed samples. After longer 
hours, the binding in hemolyzed samples actually decreased at those 
same incubation temperatures. Binding decreased in all samples in 
which hemolysis occurred at 15C.
The design utilized in this study was such that erythrocyte 
assays were performed 16 and 64 hours after collection (stored at 4C). 
While there was some variation in the results of the paired assays run 
on each sample, there was no trend indicating an effect of storage on 
assay binding parameters. Gambhir, et al, found that human 
erythrocytes can be stored for up to 72 hours at 4C without changes in
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Insulin binding. Insulin receptor sites per cell or average affinity 
constant of the empty sites [Gambhlr, et al, 1983].
When Interassay coefficient of variation (CV) was determined in 
the present study, assays were run on 5 consecutive days from a single 
Bample of blood stored at 4C. The CV was 9.3% for the 5 
determinations and the variation showed no trend over time, supporting 
the previous finding of a lack of effect of storage at AC on Insulin 
binding after 72 hours (up to 96 hours In the present study).
Demonstration of receptor association, dissociation, saturabllity 
and specificity supports that binding sites, observed In these 
studies, represent the physiological receptor for Insulin on canine 
erythrocytes and liver membranes [Llmblrd, 1986], In addition, assay 
precision was determined to assess the usefulness of these assays as 
clinical research tools. Precision in the erythrocyte assay was good 
(interassay coefficient of variation “ 9.3%), whereas precision for 
the liver membrane assay was not as good (interassay coefficient of 
variation « 25.0%).
This lack of precision In the liver membrane assay could be 
attributed to various assay techniques, Including the technique for 
separating bound from free radioligand. The double washing method 
could have Introduced significant error In CPM's by disrupting binding 
[Llmblrd, 1986]. The lack of precision makes this liver membrane 
assay, using the technique described here, undesirable for research 
and clinical purposes.
The Interpretation of the curvilinear nature of the Scatchard 
plot is not as clear-cut as previously thought [Pettersson, et al, 
1984; Sllberrlng & Wallgorskl, 1985; Llmblrd, 1986]. Previously
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mentioned physiological explanations Include: 1) multiple orders of 
non-interacting binding sites with unchanging and dissimilar 
affinities* 2) multiple affinity states of the receptor exlsitng as a 
consequence of receptor-hormone coupling when a variable fraction of 
the total receptor population is coupled to the hormone or 3) negative 
cooperatlvity [Llmblrd, 1986; Gammeltoft, 1984]. The results of the 
dissociation curves where "infinite dilution + excess Insulin" 
dissociated faster than the "infinite dilution", supports negative 
cooperatlvity, although this finding is not pathognomonic [Levitski, 
1981].
Previously mentioned technical problems can also cause the 
curvilinear shape to the Scatchard plot. Artifactual causes include: 
1) inappropriate definition of non-specific binding, 2) the 
aggregation of the ligand at higher concentrations to a dimer or 
multlmer that possess a lower affinity for the receptor and 3) a 
difference in the affinity or kinetic constants of [*H] and [H], such 
that the receptor possesses a greater affinity for r*H] than [H] 
[Pettersson, et al, 1984; Limbird, 1986],
Recent studies have supported the concept that the terminal 
horizontal part of the Scatchard plot is artlfactual and strongly 
influenced by non-specific effects [Pettersson, et al, 1984], 
Independent studies have shown that a small error in the determination 
of non-specific binding can significantly alter the number of receptor 
sites calculated from the Scatchard plot while the X maximum binding 
remains relatively unchanged rSllberring & Wallgorski, 1985].
To avoid these pitfalls, it has been suggested that only those 
points obtained from physiological concentrations of insulin be used.
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As a general rule, the highest concentration of the ligand In the 
saturation assay of hormone receptors, should be at least 5 to 10 
times the dissociation constant, which roughly represents the normal 
plasma concentration of the hormone (0.1-10 ng/ml) [Pettersson, et al, 
1984], In this study, unlabeled Insulin concentrations ranged from
0-1 X 104 ng/ml. The high-affinity portion of the curve (vertical) 
included insulin concentrations from 0 to 100 ng/ml, while the 
low-afflnity portion of the curve (horizontal) Included insulin 
concentration from 150 to 5000 ng/ml.
Two findings In this study support the previous theory that the 
horizontal portion of the curve may be artlfactual. First is the 
finding of greater variation In parameters obtained from the 
horizontal portion of the curve (total number of receptor sites, 
low-afflnity K^) as compared to parameters obtained from the vertical 
portion of the curve (high-affinity receptor sites, high-affInity K^) 
in both liver membrane and erythrocyte assays [Tables 5 & 8 ]. Ke is 
calculated from data obtained from both portions of the curve. Second 
is the finding of significant correlation between X maximum binding 
versus high-affInity receptor sites and Ke and negative correlation 
between X maximum binding versus high-affInity K^ [Tables 1 & 2],
II. INSULIN RECEPTORS OF CANINE LIVER MEMBRANES AND ERYTHROCYTES
The purpose of using liver membranes was to evaluate an organ 
considered to be a major target organ for insulin in the body. The 
use of crude liver membrane preparations offered advantages and 
disadvantages. This type of preparation was relatively easy to
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prepare and minimized potential alterations In receptors due to 
manipulations carried out in more sophisticated solubilization 
techniques [Kahn, 1976]. However, these crude membranes were more 
contaminated with mitochondrial and microsomal proteins and tended to 
have higher non-specific binding.
Although the physiological significance of insulin receptors on 
erythrocytes Is not known, erythrocytes are useful In evaluating 
various physiological states in a clinical setting. The easy 
accessablllty to large numbers of cells by way of venipuncture is an 
obvious advantage [Gambhlr, et al. 1978; Dons, 1981; Im, et al, 1983; 
Peterson, et al, 1983; Ogunwole, et al, 1985].
A potential disadvantage that has been proposed Is that 
erythrocytes are not classic target cells for Insulin. Previous 
studies have shown correlation between Insulin binding of erythrocytes 
and monocytes [Ward, et al, 1981; Kobayashl, et al, 19801 and 
erythrocytes and hepatocytes, although in the latter study erythrocyte 
receptors were less sensitive to changes In Insulin than were 
hepatocyte receptors fOkamato, et al, 19821, One of the purposes of 
this study was to attempt to correlate Insulin binding of liver 
membranes and erythrocytes. While the results did not show a 
significant correlation between any of the binding parameters 
evaluated, it is possible that correlation might be masked by the high 
variation within and among dogs ^Tables 5 & 8 ], as well as the high 
Interassay coefficient of variation for the liver membrane assay.
While attempts at correlating insulin binding parameters of 
canine liver membranes and erythrocytes were Important, comparisons, 
between tissues, of mean values for various parameters would have been
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meaningless. The 2 assays were carried out under different Incubation 
temperatures and pH's. The differences in Incubation conditions could 
account for differences in affinity constants even within the same 
tissue, making this comparison of no value. The number of receptor 
sites were determined per erythrocyte In one assay and per plcogram of 
protein In the other assay. Therefore, a comparison of the number of 
receptor sites would also have been meaningless.
Even though correlations were not evident between liver membranes 
and erythrocytes. It can be argued that receptor binding observed for 
both tissues represented binding to the physiological receptor for 
Insulin [Llmblrd, 1966], Differences In binding parameters of liver 
membranes and erythrocytes may have been due to differences In 
receptor regulation TPeterson, et al, 1983].
In addition, It Is noteworthy that In both liver membrane and 
erythrocyte binding studies, there was a correlation between the % 
maximum binding versus the number of hlgh-affinity sites and Ke and a 
negative correlation between !S maximum binding versus high-affinity 
[Tables 1 & 2]. This indicates that the total binding is a function 
of receptor number and affinity for both liver membranes and 
erythrocytes.
The argument that mature erythrocytes cannot up/down regulate the 
number of receptor sites because they lack nuclei, has been 
sufficiently overcome by the finding that receptor site numbers can be 
regulated by "internalization", a process not requiring de novo 
protein synthesis rcambhir, et al, 1981; Bathema, et al, 1981; 
Peterson, et al, 1983].
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III. THE EFFECTS OF SEX ON CANINE INSULIN RECEPTORS
In previous studies■ human erythrocyte Insulin binding has been 
shown to be senstlve to variations in plasma sex hormone 
concentrations [Bertoll, et al, I960; Hendricks, et al, 1981; Ohgaku, 
et al, 1981; Pettersson, et al, 1984], Binding In all studies was 
found to be lower In females than males. Some studies attributed this 
difference In binding to differences In receptor concentration 
[Bertoll, et al, 1980; Henderlcks. et al, 1981; Pettersson, et al. 
1984] or differences In affinity [Ohgaku, et al, 19811. When various 
phases of the menstrual cycle were compared, it was found that Insulin 
binding at the luteal phase was significantly lower than that of the 
follicular phase [Bertoll, et al, 1980].
In the present study, no significant differences were observed In 
either liver membrane or erythrocyte binding parameters due to sex. 
There was an Insignificant increase In the total number of binding 
sites and decrease In affinity of the low-afflnity receptors for 
erythrocytes from females, but as previously discussed, these binding 
parameters are probably not physiologically important.
The observation that there was a significantly higher variation 
among female dogs than a pooled value representing "within dog" 
variation, than among males for % maximum binding and the number of 
high-affinity binding sites, could be attributed to the fact that the 
6 female dogs were In various stages of the estrous cycle throughout 
the study [Appendix 5]. Because only 6 bitches were evaluted, no 
accurate comparison of binding parameters to stages of the estrous 
cycle could be made.
126
IV. THE EFFECTS OF ANESTHESIA ON CANINE ERYTHROCYTE INSULIN RECEPTORS
In evaluating 9 dogs on one occaBBion, this study was able to 
demonstrate a significant Increase In the X maximum binding as a 
result of anesthesia [Table 9]. This finding Is Important to keep In 
mind when comparing data obtained from research animals where 
anesthesia or chemical restraint may be utilized to clinical 
situations where anesethesla Is not required for blood collection.
V. THE EFFECTS OF PREDNISONE ON GLUCOSE TOLERANCE, INSULIN SECRETION 
AND INSULIN RECEPTORS IN DOGS
The results of the present study, using prednisone, were similar 
to previous studies done by our group, using prednisolone, with regard 
to glucose tolerance and insulin secretion ^Figures 24 & 25; Appendix 
6 ]. In the earlier study, we found that only the fasting plasma 
glucose concentration was significantly increased (p < 0.05) as a 
result of glucocorticoid treatment (2 mg/kg); whereas, in the present 
study, the increase in fasting serum glucose concentration after 
prednisone (1.25 mg/kg> approached significance (0.10 > p > 0.05). In 
both studies, changes in Insulin secretion noted were insignificant
( p > 0.10)  .
In the present study, body weight and food intake were closely 
monitored to assure that any observed changes in insulin receptors or 
insulin sensitivity would be attributed to glucocorticoid 
administration rather than obesity. Food intake was maintained at a
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constant level that had previously maintained an Ideal body weight.
In spite of this, a significant decrease In body weight averaging 1.1 
kg/dog, occurred fTable 12], The decrease in body weight was most 
likely due to the catabolic effects of glucocorticoids.
The insignificant increases in the X maximum binding and the 
total and high-affinity receptor sites observed at 52 hours in the 
dogs treated with prednisone were similar to the results of a previous 
study, where a significant Increase In the X maximum binding and 
receptor concentration were observed 1 day after the IV administration 
of 1 mg/kg of dexamethasone fDieberg, et al, 1986].
The changes seen in the present study may have been more subtle 
than the earlier study, because of the difference In route of 
administration, glucocorticoid formulation or, more likely, due to a 
smaller dose potency on a body weight basis.
The insignificant Increases in the total number of receptor sites 
and decreases in low-affinity after 3 weeks were unlikely to be of
physiological importance,since these parameters were obtained from the 
horizontal portion of the Scatchard plot. If these changes were 
physiologically important, they were likely due to a direct effect of 
glucocorticoids on the receptor rather than an indirect effect 
mediated through circulating blood levels of insulin (up/down 
regulation), since there was no significant change In serum insulin 
concentrations (observed fasted or when stimulated with glucose 
administration) due to glucocorticoid treatment. If the Insignificant 
increases in serum glucose (observed fasted and after glucose 
administration) due to glucocorticoid treatment, were physiologically
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Important, a possible explanation would be that of Insulin resistance 
mediated via post-receptor mechanisms.
Since the conclusion of this original study, additional clinical 
studies have been performed, utilizing the erythrocyte receptor assay 
^Personal observationsK A healthy population of pet dogs ranging in 
age from 1 to 16 years of age (n“9), a group of dogs with Cushing's 
syndrome (n«9), and a group of dogs with diabetes mellitus (n*6 ) were 
evaluated. Mean values of binding parameters for the healthy 
population were similar to the healthy dogs in the original study (*; 
maximum binding “ 4.55 versus 5.28). The dogs with Cushing's Syndrome 
had significantly decreased binding (X MB ■ 2.32) while the dogs with 
hypolnsulinemlc diabetes mellitus had significantly increased binding 
(X MB * 7.88) when compared by an unpaired t test (p<0.05). These 
results support the potential usefulness of the erythrocyte insulin 
receptor assay as a clinical research tool for use in dogs.
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CONCLUSIONS
Demonstration of receptor association, dissociation, saturablllty 
and specificity supports the theory that binding sites observed In 
these studies represent the physiological receptor for InsulIn on 
canine erythrocytes and liver membranes.
Insulin receptor binding parameters, Including the % maximum 
binding, total numbers of receptor sites, high-affinity receptor 
sites, low-affinlty K^, high-affinity and Ke, were made from 
Rosenthal/Scatchard plots and average affinity profiles. The number 
of high-affinity receptor sites and high-affinity were considered 
to be more physiologically important than the total number of receptor 
sites, low-affinity and Ke. The former parameters were obtained 
from data using physiologic concentrations of Insulin whereas the 
latter parameters were obtained from data using supra—physiological 
concentrations of insulin. Values for the % maximum binding 
correlated with the number of high-affinity receptor sites and Ke and 
negatively correlated with high-affinity K^. This finding indicates 
that insulin receptor binding is a function of both receptor numbers 
and affinity.
Interassay coefficient of variation (CV) was determined to assess 
precision for both the erythrocyte and liver membrane assays. 
Interassay CV was 9.3% for erythrocytes and 25.OZ for liver membranes. 
The precision for the erythrocyte assay allows this assay to be a 
useful clinical research tool. The poor precision for the liver 
membrane assay, using the technique described In this study, makes 
this assay unreliable for clinical research purposes.
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While changes In erythrocyte insulin receptor binding may not 
parallel changes in liver insulin receptor binding, as evidenced by 
results of this study and previous studies [Okamoto, et al, 1982], 
Insulin receptor binding still represents the physiological receptor 
for insulin on erythrocytes and liver membranes. This difference in 
binding may be due to different mechanisms of regulation of receptor 
numbers and/or affinity [Peterson, et al, 19831. It is worthwhile to 
continue to evaluate erythrocyte insulin receptor binding in clinical 
diseases or situations where insulin abnormalities are suspected, in 
an attempt to better understand the multi-faceted aspects of insulin 
function.
No significant differences were observed in mean values for 
binding parameters observed when comparing male versus female dogs 
with either liver membranes or erythrocytes. However, there was 
significant variation of the X maximum binding and the number of 
high-affinity receptor binding sites for erythrocytes among the dogs 
evaluated (variation of high-affinity approached significance).
This variation among dogs was significant for only female dogs and 
possibly attributable to cyclic variation in sex hormones occurring in 
the reproductively intact cycling female dogs used in the study.
Significant Increases in the % maximum binding of erythrocyte 
lnsulIn receptors, observed as a result of anesthesia, emphasizes the 
point that comparisons of results obtained from unanesthetized animals 
(clinical cases) to results obtained in a research setting, where 
anesthesia or euthanasia is Involved in tissue/cell collection, should 
be done cautiously.
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Significant changes In erythrocyte insulin binding were not 
observed In male dogs given prednisone when parameters were evaluated 
at 52 hours and 3 weeks after the onset of dally oral treatment. 
Insignificant Increases in the X of maximum binding and the total 
number of receptor sites and high-affinity receptor sites were 
observed after 52 hours. An insignificant Increase in the total 
number of receptor sites and decrease in low-affinity was also 
observed after 3 weeks of treatment. If these Insignificant changes 
were physiologically important, they were most likely due to a direct 
effect of glucocorticoid on the receptor rather than an indirect 
effect mediated through circulating blood levels of insulin (up/down 
regulation). There were no significant changes in serum insulin 
secretion (observed at rest or when stimulated with glucose 
administration) due to glucocorticoid treatment. If the insignificant 
Increases in serum glucose (observed at rest and when stimulated by 
glucose administration) due to glucocorticoid treatment were 
physiologically important, a possible explanation would be that of 
Insulin resistance mediated via post-receptor mechanisms.
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FOOTNOTES
a Pork mono 1125 insulin and porcine insulin* Dr. Bruce Frank* Dept, of 
Biochemistry, Lily Research Laboratories, Lily Corporate Center, 
Indianapolis, Indiana.
b Glucagon, Sigma Chemical Company, P.O. Box 14508, St. Louis, Mo, 
63178.
c Porcine proinsulin, Dr. Bruce Frank, Dept, of Biochemistry, Lily 
Research Laboratories, Lily Corporate Center, Indianapolis, Indiana, 
d Desoctapeptlde insulin, porcine, L'. Salvatore Raltl, National Hormone 
& Pituitary Program, University of Maryland School of Medicine, Suite 
501-9, 210 West Fayette Street, Baltimore, Maryland 21201-3472. 
e Homogenlzer/Bench Top Drill Press, Model 47660A, Dayton Electric Mrg 
Co., Chicago, Illinois, 60648.
f Bechman Model J21B Centrifuge, Bechman Industries, Inc., Palo Alto, 
Calif., 94304.
g Spectronic 2000, Bausch and Lomb, Analytical Systems Division, 
Rochester, New York 14625.
h Eppendorf Micro test tubes, 1.5 ml, Brinkmann Instruments, Inc., 
Westburg, N.Y. 11590.
i Fisher Microcentrifuge, Model 235A, Fisher Scientific Company, 526 
Routee 303, Orangeburg, New York, 10962.
j Serle Automatic Gamma System, Model 1185, Searle Analytic Inc., 2000 
Nuclear Drive, Des Plaines, Illinois, 60018.
k Model TJ- 6  Refrigerated Centrifuge, Beckman Industries Inc., Palo 
Alto, Calif., 94304.
1 Trichloroacetic acid, Malllnkrodt Co., Paris, Kentucky 40361. 
m CPD-A1, Terumo Corporation, Tokyo, Japan.
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n Hlstopaque, #1077-1, Sigma Chemical Co., P.O. Box 14508, St. Louis 
Mo. 63178
o Hemocytometer, American Optical Corporation, Buffalo, New York,
14215.
p Eppendorf Micro Test Tubes, 400 ul. Polypropylene, Brinkmann 
Instruemnts, Inc., Westburg, N.Y. 11590.
q Dibutyl Phthalate, Sigma Chemical Co., P.O. Box 14508, St. Louis, Mo., 
63178.
r Marshall Research Animals, North Rose, New York 14516. 
s Canine Maintenance Dog Food, Science Diet, Hills Pet Products, P.O. 
Box 148, Topeka, Kansas 66601.
t Statzyme glucose, Worthington Diagnostic Systems, Inc., Freehold, New 
Jersey.
u Insulin coat-a-count radioimmunoassay. Diagnostic Products 
Corporation, Los Angeles, Calif.
v Ivomec, MSD AGVET, Merck, and Co., Inc., Rahway, New Jersey, 07065. 
w Pentothal sodium. Chemical and Agricultural Products, Division,
Abbott Laboratories, North Chicago, Illinois, 60064.
x Metofane— methoxyfluorane, Pitman-Moore, Inc., Washington Crossing, 
New Jersey, 08560.
y 0.9% Saline, Travenol Laboratories, Inc., Deerfield, Illinois, 60015. 
z Laparoscope, Richard Wolf Medical Instruments Corporation, 7046 
Lyndon Avenue, Rosemont, Illinois, 600018.
aa Storz biopsy forcep, Karl Storz, 101II West Jefferson Blvd, Culver 
City, California, 90232.
bb prednisone, AMFAC Veterinary Supply Company, Atlanta, Georgia,
30318.
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APPENDICES
APPENDIX 1 - Assay Buffers
PH - 8.0 
Gram/Liter 
85.6 
0.60
A. 0.25 M SUCROSE 5 mM TRIS BUFFER
Sucrose
Tris Buffer Base
B. BUFFER L
KREBS-RINCERS- PHOSPHATE BUFFER PH - 7.4
CONC. GRAM/LITER
NaCI 118 mM 6 . 8 8
KCI 5 mM 0.37
MgSO^4.7H20 1.2 mM 0.30
KH-PO, 1.2 mM 0.16
2 4
NaHPO. 25 mM 3.55
4
CaCl2 .2H20 1.3 mM 0.147
BSA* IX 10.0
* Bovine Serum Albumin
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APPENDIX 1 continued
C. PHOSPHATE BUFFERED SALINE (PBS) PH - 7.4
20X GRAMS/LITER
NaCl 160
KC1 4
Na-HPO. 232 4
KH„PO, 42 4
then add 50 ml to distilled water to q.s. 1 liter
D. BUFFER G PH - 7.6
mM/Liter Crams/liter
HEPES Buffer 50 13.0
Tris pH 7-9 50 6.06
MgCl,,. 6H00 10 2.03
EDTA (DiNaSalt) 2 0.67
Dextrose 10 1.80
NaCl 50 2.92
KC1 5 0.37
CaCl2 .2H20 10 1.47
BSA* 1 0 . 0
♦Bovine Serum Albumin
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APPENDIX 2
3. LOWRY SOLUTION
50 PARTS
1 PART
APPENDICES
"LOWRY A" : Na2C03 20 grams/liter
NaOH 4 grams/liter
NaK Tartrate 0.2 grams/liter
"LOWRY B" IX CuSO..5H_04 2
APPENDICES
APPENDIX 3
CPD-AI
Citrate Phosphate Dextrose Adenine Solution (63 ml) 
contains:
Citric Acid Hydrous 206 mg
Sodium Citrate Hydrous 1.66 grams
Monobasic Sodium Phosphate Hydrous 140 mg
Dextrose Anhydrous 1.83 grams
Adenine 17.3 mg
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APPENDIX 4
CONTENTS OF CANINE MAINTENANCE DIET (DRY)
Carbohydrate 45.92
Protein 23.02
Fat 14.52
Fiber 3.32
kcal/gram 3.9
calories/cup 336
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APPENDIX 5
APPENDICES
VAGINAL CYTOLOGY OF SIX BITCHES DURING STUDY
Week
Dog 2-19-86 3-5-86 3-21-86 4-5-86 4-18-86 5-2-86 5-16-86 5-30-86
__________Sampling__________
I D  D A  A A  A A  A
2 E D D  D D  A A  A
4 A A P  E D  D D  D
------  ----- -— —  ---------   Sampling_________
7 P E D  D D  D A  A
8 P E D  D D  D A  A
12 A P E  D D  D D  A
A “ Anestrus 
E * Estrus 
D “ Diestrus 
P * Proestrus
Appendix 6
"Effects of prednisolone on glucose tolerance 
and insulin secretion in the dog"
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Effects o f prednisolone on glucose tolerance and insulin 
secretion in the dog
K  J  W o ifth tim tr , DVU. W Flory. PhD; U  D. WiUiom*, DVU, PhD
SUMMARY
Effects of prednisolone on glucose tolaranca and insulin  
secretion w on  oval us lad in Iw hlqF d o p . D o p  were given 
1 m g of pr*dnieolone/kg of body w eight/day In *■ 5) or 2 
m g of pradniaolona/kg/day In ■ 6) orally  for 3 w eeks 
In travenous glucooo tolaranca taata <600 mg/kg) worn ad­
m in istered  before and afta r trea tm en t to avaluata  plasm a 
glucoaa in  fa ttin g  doga, glucoas fractional clearance ra ta , 
■arum insulin  in  fasting  dogs, insulin  paak rasponss, to ta l 
in su lin  aacration, and insulinoganic indax.
A signiAcant difference (7* < 0.06) in  plasm a glucoaa 
in  Easting dogs was obasrvsd for tba 2 mg/kg dose, a l­
though values w ars still w ithin tha reference rang* Thsra 
was no signiAcant offset on g lucoas fractional claaranca 
ra ta  I glucoaa tolaranca) or insulin  secretion. Seem ingly, 
peripheral insu lin  resistance resu lting  in  hyperinauline- 
m is  or decreased glucoaa tolerance could not be identified 
in association w ith 1 or 2 mg of predmeolone/kg/day for 
3 weeks in healthy  dogs.
In th e  dog, secondary diabetes m ellitua has bean asso­
ciated w ith glucocorticoid excess ' T ha concurrent p res­
ence of diabetes m ellitua and hyperadrenococticism ia 
reported in the  dog.11 Glucoaa in tolerance and overt di­
abetes m ellitua developed in a  dog afte r prolonged exog­
enous adm in istra tion  of glucocorticoids *
Hyperglycemia associated with glucocorticoid excess may 
be caused by increased hepatic gluconeoganeeis, as well 
as  decreased use of glucose in  tissues.'**  A lthough in ­
creased hepatic gluconeogeneeia caused by glucocorticoid 
adm in istra tion  in  tha dog is well docum ented,1 * th a  eval­
uation  of peripheral glucoas up take in  association w ith  
insu lin  function is not a s  well descr ibed in  th a  dog as  it 
ie in hum an beings.1
In relation  to  glucose uptake, insulin  facilita tes glucose 
tran sp o rt across call m em branes in muscle, adipose, o ther 
tissues, and  leukocytes, a s  well as  allow ing phosphory­
lation of glucose in th a  l iv e r1* Insu lin  in te racts w ith spe­
cific call m em b ran e  recep to rs  to  in i t ia te  a se rie s  o f 
in tracellu la r postreceptor events, including glucose u ti­
lisation.
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In hum an beings and  rats, glucocorticoids can induce 
insulin resistance a t th e  ta rge t cell and  therefore resu lt 
in  hyperglycemia.**"**1 The m echanism  for insulin  re­
sistance ia uncerta in .•*1#"
W ith insu lin  resistance, a com pensatory action occurs 
in  th a  body resu lting  in  increased c ircu lating  insulin con­
cen trations to  effect proper glucoaa use .'*  Prolonged ex­
cessive stim ulation of pancreatic 6 cells to produce insulin 
in a situation  of insulin  resistance could resu lt in  ex­
haustion  of tb s  6 cells and th u s  lim it insulin  secre­
tion.**11 T he resu lt of lim ited insu lin  secretion or a 
pronounced insu lin  resistance is hyperglycem ia and re ­
lated  metabolic derangem ents in  association w ith gluco­
corticoid excess Although hyperinsulinem ia may be caused 
by insulin  resistance, th e re  is also evidence to support a 
d irect stim ulatory  effect o f glucocorticoids on 0-cel) se­
cretion.* *■
The purpose of th e  presen t report w as to  evaluate the 
effects of short-term  prednisolone trea tm e n t on healthy 
dogs. P lasm a glucose and  serum  insulin  concentrations 
w ere m easured in  response to a n  rv does of glucoes as a 
m eans of evaluating  a ltera tions in  glucose/insulin ho­
m eostasis caused by prednisolone trea tm en t.
Materials and Methods
Dog*—Eleven healthy adult doge <6 males, and 6 sneetrsl 
females) were conditioned to housing and • commercial dog food* 
<41% carbohydrate dry weight! for 2 weeks. These dogs were of 
various breeds, ranged in body weight from 17.3 to 29 5 kg. and 
were within 10% of ideal body weight. A constant amount <30 
g of dog food/kg of body weight) was fed daily and water was 
given ad libidum.
The dogs were seeigned to 2 groups. One group (3 males and 
2 females) wee given 1 mg of predniaolone/kgrdisy orally The 
other group (3 males, 3 females) was given 2 mg of prednisolone/ 
kg/day orally. Both groups were treated for 3 weeks.
Intravenous glucose tolerance tests won performed before and 
after the 3-week treatment in each dog. Doge were fasted 24 
hours before administration of 600 mg of gluooaa/kg iriven as 
50% dextrose) over a 30-e period via cephalic catheter. TTui dose 
allowed maximal stimulation of insulin secretion without uri­
nary loas of glucose during the IS to 45 minutes when fractional 
clearance rates of glucose w en  determined "  This does gave 
results similar to those obtained with the more widely accepted 
dosage rate of S00 mg of glucose/kg.^** Glucose determinations 
before IS minutes were not used in the determination of frac­
tional clearance rates, because those values exceeded the renal 
threshold, therefore, they would result in urinary lose of gluroaa 
which would inaccurately increase fractional clearance rate.**
Plasma glueot* ctmmnfrorioae— All blood samples were col­
lected through an indwelling jugular catheter and taken before 
and 5, 10. IS. 26, 35. 45 a id  60 minutes after glucose admin- 
istration. Serum samples far insulin values were collected, al-
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lowed to clot, w on centrifiiged, and immediately asperated and 
frusen o t -  20 C until assayed. Plasma sample* for glucose con­
centration* w o n  colloctod in EDTA. immediately centrifiiged, 
and froaan a t  -  20 C, Oluooao concentration* w o n  dotonninod 
■pectrophotometrically, uawg tho flucooo oxidase method.* A 
reference rang* of can in# plasma flucooo concentration wao de- 
torminod from 26 healthy do(* to bo botwoon 80.0 to 106.0 mg/ 
d! with a moan of 93.6 ( ± 1 so  -  8.6)
Scrum insulin conconlruttono—Inaulin valuoo for oorum *am- 
pleo w on  dotonninod by rndioimmunoaoaay, uaing a commer­
cially available kit for uao in human being*' Specificity for 
canine inaulin waa evaluated by demonatrating dilutional par- 
allelitm  between atondard aolutiona and aerial dilution* of en­
dogenous inaulin in canine oorum Biological apociflcity waa 
dem onstrated by rovaaling injected glucooe atiraulated an in- 
craaao in aerum inaulin concontrationa in hoalthy dog*, a* well 
aa by the m oaaunm ent of incnaaod inaulin concontrationa (64 
pJU'ml i in a faated dog with hiatologically confirmed pancreatic 
6-cell adenocarcinoma. Accuracy waa demonatrated by the ad­
dition of porcine inaulin fbocaue* the amino acid sequence waa 
identical for porcine and canine inaulin and purified canine in ­
aulin waa unavailable) to canine aerum in concontrationa from 
4 to 200 pJU m l Linear legi aaaion analysis of the recovery curve 
demonatrated a correlation coefficient (r) of 0 998 Low-end een- 
aitivity for the aaaay, defined a* the apparent concentration 2 
SD below the counts at maaimum binding, waa 1
The intra-aaaay preciaion for 18 replicate* (9 duplicated a tm  
plea) of canine aerum with a mean concentration of 38 3 pIU/ 
ml revealed a coefficient of variation of 3.7%. The interaaaay 
coefficient of variation for 9 aaaay* on the aame canine aerum 
aample waa 13%.
The reference range of inaulin concentration* in canine *enim 
determined from 61 healthy dog* of various breed* (31 male* 
and 30 aneatral females), waa 2 6 to 20.0 p lU m l The mean was 
7 8 I ± I so  -  3.9)
The following wore evaluated from the rv glucoae tolerance 
test: (i) plaama glucoae concentration in fasting dog*, fii) frac­
tional clearance rate of glucoae, (iii) aerum insulin concentra­
tion in fasting dog*. Iiv) insulin peak response, (v) total inaulin 
a aerated, and <vi) insulinogenic index.
The fractional clearance rate  was calculated a* the slope of 
the line (0 693/half-life I t i J  * 100, aa percentage per minute) 
for plasma glucose values taken between 15 and 45 minutes 11M 
The insulin peak response was considered to be the highest 
increment of aerum inaulin above the base-line (aample taken 
before rv glucoae) aerum inaulin concentration. Total insulin 
aacration waa estim ated aa the total incremental insulin area 
above the base line during the 60 minutes of the teat The m- 
eulinogenic index was defined as the ratio of insulin peak re­
sponse to the greatest glucose increment above the concentration 
in fasting dogs (5 minutes) *1
Statistical analysis was performed uaing the paired t teat IP 
< 0.05) “
Results
All doga developed clinical aigns of hyperglucocorti- 
coidism, including polyuria, polydipsia, and increased ap­
petite.1'4 Although aonie doga had pendulous abdomens 
and muscle wasting, there were no significant changes in 
body weight for the treatm ent groups.
Plasma glucose concentrations in fasting dogs were sig­
nificantly increased after treatment with the 2 mg/kg 
dosage (P < 0.05). The mean glucose plasma concentra­
tion in fasting dogs increased from 87 mg/dl to 97 mg/dl,
* a u u j m  f t w a a ,  W w tU aetsa D i s e n l i t  iywtimt lac. frasbaid NJ
" lasulis a U c w n l  ratoMauBemawey. Diafaaatic PraUucu Corp. taa Ae- 
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D*f No Boforo AfWr B*for* After
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1 102 103 5 01 424
2 199 71 3 5 2 3 07
2 ift 90 2 2 5 3 47
4 rr 92 2 45 421
5 1QI 107 1.92 3.97
X * i m u 100 * 4 93 * 0 30 3  = 0 5 9 3 90 * 023
R u i« U  -  109 71 -  107 1 92 - 5 01 3 07 - 4 24
Gftoirr 2
6 SI f i 39ft 222
7 #3 99 2 15 294
2 SO 99 2 92 2 50
2 102 107 2 97 254
10 #1 90 4 41 2 78
-  u 9ft 109 2 75
X 4 1 KM 17 :  4" 0 7 - 4 * 31 3  * 03 4 2 37 * 0 OA
90 - 102 9 9 - 1 0 9 21 6  -  4 41 2 50 - 2 70
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X O K U «  t  9 99 * 3 3 13 ♦ 0 30 3 1 3 ?  0 22
R gnft 9 0 - 1 0 4 71 -  109 1 92 - 3 01 2 22 - 4 24
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Fig t— Effect* ol prednisolone on  g lu co se  tolerance during tv g lu cose  toi- 
eren ce  lee t (600  m g-kgf O  % -  m ean  va lu es tor healthy nontreaied  
dog* (n -  11). -  m ean  value* tor dog*  treated with t m j d
D redm sotone/kgdey (n -  6). and A  A “  m ew i v e to es  tor dog* treated
wMi 2  m g erf prednwotoneiig/daiy
although remaining within the reference range (87.0 to 
101.0 mg/dl). This range was determined by use of the 
same procedure for glucose determination on plasma 
samples from 2$ healthy dogs.
After prednisolone was given to the doga, mean glucoee 
fractional clearance rates slightly increased in those given 
the 1 mg/kg dosage and slightly decreased in those given 
the 2 mg/kg dosage N either changes were significant iP 
> 0.05; Fig 1).
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Fig 2 — Effsct* Ol prodmsoton* c m  m a u M n  ■ac f i qn during <v gluc059 101- 
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There were no significant changed in inaulin value* in 
fasting dogo or in inaulin peek reaponae in either group 
when compered with pretreatment veluee. Decreaeea in 
mean to tel inaulin secretion were obeerved in both groupe, 
but were not significant A change waa not noticed in the 
inaulinogenic index for the 1 mg/kg doee group, but there 
waa an insignificant decrease in the 2 mg/kg doaage group 
(Fig 2)
Discussion
The hyperglycemia and glucoae intolerance seen with 
glucocorticoid exceaa ere aaaociated with hepatic and pe­
ripheral inaulin resistance.*101* Inaulin usually acta to 
suppress enzymes involved in hepatic gluconeogenesis,7 * 
aa well ea to facilitate glucose utilization in peripheral
tissues.*0 17 In acute studies, methyl prednisolone or cor­
tisol decreased or did not affect glucose production and 
utilization.7 ** More prolonged glucocorticoid excess (5 to 
7 days) causes an increase in glucose production and uti­
lization.7 * In 1 study,17 the increased rate of utilization 
may have been inappropriate for the degree of hypergly­
cemia and hyperinaulinemia, thus reflecting a relative 
peripheral insulin resistance.
The increased glucose concentrations in fasting dogs 
after 2 m ghg treatment with prednisolone could be caused 
by a decreased inaulin suppression of hepatic gluconeo- 
genesis (hepatic insulin resistance). The lack of increase 
in serum insulin values (lasting or in response to glucose 
challenge) indicates that peripheral inaulin resistance was 
minimal or nonexistent. However, peripheral insulin re­
sistance cannot be ruled out, because values measured in 
the present study were limited. Demonstration of periph­
eral inaulin resistance may require elaborate glucose clamp 
techniques, monocompartmental analysis, uaing tritium- 
labeled glucose, and m inimal model methods.1* 17 **
The mechanism for insulin resistance ia uncertain.*1011 
Increases and decreases in inaulin receptor numbers1* 1*J0** 
and affinity1* 10 ia 10111411 have been found in studies of 
in su lin  receptors on hepatocytes.*4 "  adipocytes,19 47 
erythrocytes,1*10 ,1 and leukocytes.1* 1*'10 These conflict­
ing results may reflect differences in experimental design 
and duration, different tissue effects o f glucocorticoids, or 
differences in glucocorticoids used in the studies.11 One 
proposed explanation for the discrepancies seen in var­
ious studies is that increases in receptor numbers or af­
finity may be caused by a direct effect of glucocorticoids, 
whereas the decreases in receptor numbers or affinity may 
reflect a secondary response to increased circulating in­
sulin values directly caused by glucocorticoids (so-called 
dow n-regulation).17■l* Insulin resistance of glucocorti­
co id s m ay a lso  be ca u sed  by p ostrecep tor  de-
The findings of decreases in insulin peak response and 
total insulin secretion were surprising, because an in­
crease in insulin secretion would be expected with glu­
cocorticoid excess * 1414 Increased insulin secretion would
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be oxpeetod b*c«ui* glucocorticoids may incrauo inaulin 
aacration indirectly by inaulin rasiatanca and/or by hav­
ing a direct stimulatory affect on steroid receptor* on pan­
creatic 0  cells to increase inaulin secretion directly *7 
Peterson at al'-* found an increase in insulin peak re­
sponse and total insulin secretion in 8 dogs with hyper- 
adrenooortidsn. With longstanding hyperadrenooortidsni 
and p-call exhaustion, decreases in inaulin values in fast­
ing dogs, insulin peak response, and total inaulin secre­
tion may be eeen.1*11 TV* decrees ss in insulin peek response 
and total insulin secretion were not significant and prob­
ably not physiologically important in view  of absence of 
significant changes in glucose fractional clearance rates 
and absence o f histopathologic changes in pancreatic islet 
cells in 4 dogs examined histologically.
Peripheral insulin resistance in healthy dogs is mini­
mal at doses of 1 and 2 mg o f predniaolone/kg/day for 3 
weeks and is not detectable by the values evaluated. Uee 
of more sophisticated techniques may be effective in doc­
umenting insulin resistance in dogs in the future From 
a clinical standpoint, healthy dogs have the capacity to 
tolerate therapeutic doses of glucocorticoids for short pe­
riods while m aintaining glucoee/insulin homeostasis.
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